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ABSTRACT
Background. Neural tube defects are one of the leading congenital malformations that
affect children in Latin America and worldwide, leading to pregnancy terminations, morbidity,
mortality, and long-term disability. The most cost-effective and equitable way to prevent them is
by implementing public health policies for food fortification with folic acid. However, a lack of
knowledge translation strategies partly accounts for the incomplete enactment, enforcement, and
scaling-up of mandatory fortification. There is no evidence in the scientific literature of studies
attempting to identify the factors contributing to the development and implementation of
knowledge translation strategies aiming to influence policymakers’ decisions regarding mandatory
food fortification to prevent neural tube defects in Latin American countries.
Objectives. The study's overall purpose was to describe the factors contributing to
developing and implementing a knowledge translation strategy, named the NeuroAdvocacy
Toolkit, aiming to influence policymakers in Latin American countries regarding mandatory
food fortification policies to prevent neural tube defects.
Methods. This study utilized a mixed-method sequential explanatory design with a
follow-up explanations variant, which prioritizes the initial quantitative phase and uses the
subsequent qualitative phase to explain the quantitative results. The study comprised three
phases. First, a document analysis led to determining the status of fortification policies and a
needs assessment for regulation change in the 20 Latin American countries, followed by the
development of the NeuroAdvocacy Toolkit. The toolkit development was informed by the
scientific literature and voices from the target audience regarding preferred mechanisms for
knowledge transfer and utilization. Second, a quantitative phase collected survey data from
purposefully selected Latin American key opinion leaders through the Measurement Instrument
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for Determinants of Innovations (MIDI) to identify the barriers and facilitators for implementing
the toolkit as an innovative knowledge translation strategy. The surveys were conducted through
an online platform in Spanish. And third, a qualitative phase gathered interview data about the
perspectives of Latin American key opinion leaders in pediatric neurosurgery (purposefully
selected from the survey respondents) on implementing and disseminating the toolkit to
policymakers. The interviews were conducted through an online platform in Spanish. This phase
concluded by integrating quantitative and qualitative data to gain a deeper understanding of how
to address the critical factors.
Results. The document analysis in the study's first phase triangulated different sources of
information to identify the status of food fortification policies in Latin America and develop a
reliable needs assessment for regulation change. The data gathered allowed categorizing the 20
countries according to the priority to implement regulatory changes to strengthen fortification
policies. Four countries are in level 1 priority with an urgent need for regulation change, 14
countries are in level 2 with a high need for regulation change, one country is in level 3 with a
medium need, and one is in level 4 with no need for regulatory change. After being introduced to
the NeuroAdvocacy Toolkit, 30 key opinion leaders in pediatric neurosurgery from 20 countries
responded to the MIDI questionnaire. Their responses allowed identifying 20 facilitators, seven
potential facilitators, and two barriers to implementing the Toolkit as a knowledge translation
strategy targeting policymakers in the region. Twenty-four interviews with key opinion leaders
yielded three themes describing 1) the attitudes toward using the Toolkit, 2) the ideal delivery
strategies to policymakers, and 3) how to face potential challenges when bringing policymakers
on board during the implementation and dissemination process. Finally, integrating quantitative
and qualitative data permitted a deeper understanding of overcoming potential barriers and
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strategically leveraging facilitating factors when disseminating the Toolkit to the target
policymakers. Although the MIDI allowed identifying the main barriers and facilitators for
implementing the NeuroAdvocacy Toolkit, the subsequent interviews allowed visualizing
alternatives for operationalizing the determinant factors. Key opinion leaders’ behaviors,
influenced by subjective norms, social norms, and perceived roles, can spearhead effective datadriven advocacy. Organizational support can enhance the implementation and dissemination of
the NeuroAdvocacy Toolkit by consolidating neurosurgical guild unity and promoting alliances
with universities, other academic institutions, and other professional societies; also, obtaining
support from non-governmental organizations and patients’ associations as critical stakeholders.
Gaining support from supranational organizations such as the WHO and PAHO, materialized
through a statement or resolution, can accelerate the dissemination process and promote the
promulgation, enactment, and enforcement of MFF policies in most of the countries represented
in this study.
Conclusions. Most Latin American countries have a compelling need to update, scale up,
implement, optimize surveillance, and guarantee the sustainability of mandatory food
fortification policies to prevent neural tube defects. The NeuroAdvocacy Toolkit is an innovative
knowledge translation strategy enabling key opinion leaders in pediatric neurosurgery to
influence policymakers' decisions toward strengthening fortification policies in Latin America.
Critical determinant factors can act as barriers or facilitators to implementing and disseminating
the Toolkit. Recognizing them is essential to tailor strategies to approach and call policymakers
to action, with the ultimate goal of saving thousands of children in Latin America from being
born with a devastating but preventable condition and promoting a healthy and fulfilling start to
their lives.
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The NeuroAdvocacy Toolkit: A Knowledge Translation Strategy to Strengthen Food
Fortification Policies to Prevent Neural Tube Defects in Latin American Countries.
A Mixed-Method Study
Chapter 1: Introduction

Thousands of children can be saved from being born with a neural tube defect (NTD), a
disabling congenital condition that affects the proper development of the brain and spine. A large
percentage of the cases are preventable by implementing mandatory food fortification (MFF) with
folic acid, an evidence-based public health measure that has shown to be efficacious, practical,
safe, feasible, and cost-effective in preventing NTDs (CDC, 2020c; Kancherla, 2018; Pachón et
al., 2013). Despite these facts, worldwide only 63 countries have implemented this evidence-based
policy, while most have focused on just one type of staple food (primarily wheat flour) (FFI, 2022;
Kancherla, Botto, et al., 2022), while other essential staples are left out, hindering that this
intervention reaches the most vulnerable population.
Different determinant factors acting as barriers or facilitators for the reach, adoption,
implementation, and scaling-up of MFF as an evidence-based policy are evident in the literature
(CDC, 2020a; Estevez-Ordonez et al., 2018; Field et al., 2018; Kancherla, 2018; Kancherla, Botto,
et al., 2022; Martinez et al., 2021). They comprise individual and contextual factors that may vary
according to specific circumstances. However, there is scarce information in the literature
regarding theories, models, frameworks, or knowledge translation interventions that address how
to overcome those barriers or leverage the facilitators to implement MFF effectively and
successfully to prevent NTDs.
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In Latin America, despite meaningful progress in public health policies regarding MFF for
the prevention of NTDs, the reach of these policies is still insufficient. The presence of MFF
legislation is uniform in the Latin American region for wheat products; in contrast, it is incomplete,
in some cases voluntary, and often null for maize and rice, two essential staple foods in the diet of
millions of Latin Americans (FFI, 2022; Rosenthal et al., 2014; Zaganjor et al., 2016). A scoping
review identified key barriers and facilitators for implementing MFF (Ghotme, 2018). On the one
hand, some of the obstacles include insufficient translation of the evidence to support MFF policies
and a lack of willingness from local authorities in many countries to either enact regulations for
this evidence based-policy or to provide sufficient oversight to ensure that industry and importers
follow the rules for mandatory folic acid fortification (Estevez-Ordonez et al., 2018; Martin et al.,
2011; Mills, 2017). On the other hand, advocacy and leadership of neurosurgical individuals and
groups stand out as potential facilitators for knowledge translation to policymakers due to their
accumulated experience dealing with these conditions and their high standing in society (EstevezOrdonez et al., 2018).
Statement of the Problem
A lack of knowledge translation strategies is responsible, in part, for the incomplete
enactment, enforcement, and scaling-up of MFF as an evidence-based policy to prevent NTDs in
Latin American countries, hindering the protection of thousands of children from these disabling
conditions. There is no evidence in the scientific literature of studies attempting to identify the
factors contributing to implementing knowledge translation strategies that aim to influence
policymakers’ decisions regarding MFF to prevent NTDs in Latin American countries or
worldwide.
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The consequences of not addressing the problem have an impact on four levels. First, in
public health, due to an increased incidence of cases, pregnancy terminations, stillbirths,
morbidity, and mortality. Second, at a societal level, due to increased costs to the healthcare system
for unnecessary allocation of resources and efforts to treat a preventable condition. Third, at a
family level, causing an increased burden of disease to caregivers and family dysfunction, as well
as increased use of family time and resources. Fourth, at the individual level, these patients present
significant long-term physical disability, need for complex care, dependence on different aids, and
psychosocial issues.
Purpose
The study's overall purpose was to describe the factors contributing to developing and
implementing a knowledge translation (KT) strategy aiming to influence policymakers in Latin
American countries regarding MFF to prevent NTDs. The strategy involved the participation of
key opinion leaders (KOL) at the Latin American Society for Pediatric Neurosurgery
(ASOLANPED). A core strategy component was developing a KT toolkit, denominated the
NeuroAdvocacy Toolkit, aimed to broker knowledge to policymakers. The ultimate goal was to
design a dissemination strategy tailored to the needs for regulatory change and contextual aspects
of Latin American countries.
Research Questions
This study answered the following overarching research question: how may we describe
the factors contributing to the development and implementation of a KT strategy aiming to
influence policymakers regarding MFF for preventing NTDs in Latin American countries?
This question gave rise to quantitative, qualitative, and mixed-methods research questions,
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presented in Table 1.1.

Table 1.1 Quantitative, qualitative, and mixed-methods research questions of the study
QUANTITATIVE

QUALITATIVE

MIXED-METHODS

RESEARCH

RESEARCH QUESTIONS

RESEARCH QUESTION

QUESTION
What are the

How do the KOL describe their

In what ways do the

determinant factors

attitudes toward implementing and

interview data reporting the

influencing the use of

disseminating the NeuroAdvocacy

views of KOL about using

the NeuroAdvocacy

Toolkit to translate knowledge to

the NeuroAdvocacy Toolkit

Toolkit as an

policymakers in their countries?

help to explain the

innovation to promote

What are the perceptions of

quantitative results about

robust MFF policies

KOL about appropriate dissemination

the determinant factors for

in Latin America?

mechanisms of the NeuroAdvocacy

implementing the

Toolkit?

innovation?

Note: MFF: mandatory food fortification; KOL: key opinion leaders
Statement of Potential Impact
This study generated knowledge regarding effective KT strategies to strengthen public
health measures to prevent NTDs by bridging the chasm between scientific evidence and
implementing public policies for MFF (bridging the T3 and T4 moments of the translational
research continuum, which implies translating knowledge from scientific evidence to populations).
This KT process is associated with impacting policies for improved disease prevention and reduced
costs for medical care (Waldman & Terzic, 2010). The present study included the development of
a KT strategy (the NeuroAdvocacy Toolkit) and analyzing the critical factors for implementing
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and disseminating it, aiming to influence policymakers in Latin American countries regarding
MFF policies for the prevention of NTDs. The ultimate goal of the KT strategy is to increase the
likelihood that research evidence on the prevention of NTDs reaches policymakers and influences
their decisions to ensure the reach, adoption, implementation, scale-up, and sustainability of MFF
as a robust evidence-based policy to prevent NTDs. In the long term, properly implementing and
enforcing MFF policies will eventually lead to improved health outcomes for individuals,
impacting families, society, and public health.
On the other hand, the development, implementation, and dissemination of the KT strategy
proposed in this study can help address some of the unmet needs of global neurosurgery in its five
domains: strengthening health systems, education, research, practice, and advocacy. Global
neurosurgery prioritizes improving health outcomes and decreasing health disparities for humans
affected by neurosurgical conditions or requiring neurosurgical care worldwide (Park et al., 2016).
Conceptual Framework
This study’s primary constructs are:
•

Mandatory food fortification

•

Determinant factors (barriers and facilitators) of innovation

•

Knowledge translation strategies

•

Knowledge brokers (key opinion leaders)

•

Knowledge users (policymakers)

•

Dissemination of evidence-based policies

•

Stakeholder engagement

•

Advocacy, leadership, and lobbying

6

The reason for prioritizing those primary constructs was that the evidence of MFF's
efficacy, safety, and cost-effectiveness as a successful evidence-based policy is already compelling
and has been available for more than three decades (CDC, 2020c; De-Regil et al., 2015, 2016; FFI,
2022; Kancherla, 2018; Martinez et al., 2021; Pachón et al., 2013; Tablante et al., 2019). Therefore,
this study focuses on the mechanisms to bridge that gap by translating knowledge to decisionmakers and influencing the scale-up and optimization of MFF policies while understanding the
determinant factors for implementing and disseminating such strategies.
Kingdon’s model describes how the convergence of problem, policy, and political streams
opens a window for policy entrepreneurs to promote new policies that enter the agenda of
policymakers (Kingdon, 2014). However, this model does not account for the critical factors
influencing the uptake of a specific evidence-based policy. Aaron’s model incorporates those
factors, but it does not consider the three streams of Kingdon’s model. Therefore, a combination
of both models integrated streams and critical factors based on a published experience in mental
health using this approach (Aarons et al., 2011). Figure 1.1 illustrates the conceptual framework
created explicitly for this study using both models.
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Figure 1. 1 A conceptual framework combining Kingdon’s and Aaron’s models for alignment of
multiple streams and contextual factors to disseminate mandatory food fortification as an
evidence-based policy to prevent neural tube defects

Note. Ghotme - Own work, Based on Purtle, Dodson & Brownson (2018)
The Knowledge to Action framework addresses the process of translating knowledge to
actions as an iterative, dynamic, and complex process. It concerns the creation (knowledge funnel)
and application (action cycle) of knowledge (Graham et al., 2006; Straus et al., 2011). Although
the framework constitutes a cycle, users may need to utilize the phases out of sequence, depending
on the project. In this case, the development of a knowledge tool was followed by the assessment
of determinant factors for knowledge use and the selection, tailoring, and implementation of a KT
intervention (Figure 1.2).
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Figure 1. 2 Specific steps of the Knowledge to Action Framework used in this study

Note. Adapted from the Knowledge to Action Framework (Graham, 2006), retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/16557505 (2020)

Summary of the Methodology
This study used a mixed-method explanatory sequential design to describe the factors
contributing to the development and implementation of a KT strategy aiming to influence
policymakers regarding MFF to prevent NTDs in Latin American countries. The selected design
used the follow-up explanations variant, which prioritizes the initial quantitative phase and uses
the subsequent qualitative phase to explain the quantitative results (Creswell & Plano Clark, 2017).
The rationale for collecting quantitative and qualitative data was to obtain a deeper understanding
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of the critical factors for developing and implementing the innovation (the NeuroAdvocacy
Toolkit), along with the KOL’s engagement, motivation, intention to act, and mechanisms for
disseminating it. Studying those aspects together is unaccountable with one source of data only.
In dissemination and implementation research, mixed-method studies are the preferred
design to identify the determinant factors acting as barriers or facilitators to implementing
innovations. Besides, they help develop strategies and conceptual models of implementation,
monitoring the implementation process, and increase the probabilities of the long-term
sustainability of successful innovations (Palinkas & Cooper, 2018).
The selection of this design was founded on a pragmatic worldview combining quantitative
and qualitative approaches. It drew elements of the multiple streams model for policy
dissemination (Kingdon, 2003, 2014) and the Knowledge to Action Framework (Graham et al.,
2006).
The study followed Maxwell’s interactive model for research design to align the theoretical
framework with the goals, research question, and methodology (Maxwell, 2012). It generated
trustworthy, credible, confirmable, and transferable data on effectively using a toolkit to translate
knowledge to decision-makers for strengthening evidence-based policies to protect thousands of
children from NTDs as disabling but preventable conditions.
The study comprised three sequential phases, illustrated in Figure 1.3. The three-phases
layout facilitated a logical sequence of the study's main activities and outputs.
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Figure 1. 3 Phases, activities, and outputs of the study

Note: Ghotme, own work, created with SmartArt. MIDI: Measurement Instrument for
Determinants of Innovations
In the first phase of the study, a document analysis provided factual data regarding the
status and content of current legislation for MFF in the 20 Latin American countries, along with
the national prevalence of NTDs and nutritional situation. The data gathered were codified to
explore common ground (or lack thereof) in terms of policies, followed by a needs assessment for
regulatory change contextualized to each country. According to the needs assessment, countries
were classified into four categories: urgent need, high need, medium need, and no need for
regulatory change. To include the voices of the innovation's target audience in designing the
Toolkit, semi-structured interviews with pre-set topics were conducted with three selected
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policymakers from different countries to explore goals, expectations, and preferred mechanisms
for knowledge translation. This phase's output was the NeuroAdvocacy Toolkit's development as
the innovative KT strategy.
The second phase gathered quantitative survey data from KOLs at the national pediatric
neurosurgery societies in Latin America regarding the determinant factors for implementing the
NeuroAdvocacy Toolkit. Before data collection, the toolkit was introduced and explained to the
KOLs at in-person scientific and online meetings. Subsequently, the Measurement Instrument for
Determinants of Innovations (MIDI) was applied online, in Spanish, through SurveyMonkey®, an
open-source software tool. The survey was pilot-tested on three participants and adjusted
accordingly. Data were processed in SPSS version 27. Quantitative data analysis of the survey
answers included descriptive statistics focused on the proportion of respondents in agreement with
the statements inquired. The frequency of responses for each factor was analyzed according to the
respondents’ country and then organized through a joint display table for contingency analysis.
This phase yielded additional refinement of the NeuroAdvocacy Toolkit in response to the
identified barriers and facilitators to the innovation by the KOL in a way that retains the core
components but contains customizable elements adaptable to local contexts.
The third phase collected qualitative data from semi-structured interviews with the KOLs.
The questions explored their engagement, motivation, intention to act, and ideal delivery
mechanisms of the NeuroAdvocacy Toolkit. The content of the interview protocol was grounded
in the quantitative results of the study's second phase. The interview questions focused on the
central phenomena related to their perspectives on the factors influencing the implementation of
the NeuroAdvocacy Toolkit. The interview protocol was pilot-tested on one participant,
purposefully selected from those who had completed the survey in Phase 2, and adjusted
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accordingly. All interviews were conducted online, in Spanish, through the Zoom® platform, and
recorded in a secure storage location. The recorded interviews were transcribed verbatim through
the Microsoft 360® transcript software. Data were analyzed and coded for thematic analysis of the
participants’ perspectives. The analysis was performed at two levels: within each case (individual
interviewees) and across the cases (Creswell & Plano Clark, 2017). A matrix structured in terms
of the themes, subthemes, and codes was used for displaying and further developing the results,
including the verbatim quotes that addressed or supported those categories (Maxwell, 2012).
Memoing and bracketing procedures were used to mitigate the potentially deleterious effects of
the researcher’s preconceptions. Trustworthiness was secured by triangulating different sources of
information, member checking, rich and thick descriptions of the cases, and reviewing and
resolving disconfirming evidence.
Finally, quantitative and qualitative data were synthesized and integrated. A joint display
table was developed to illustrate how the qualitative results enhance the quantitative results. The
value added by the qualitative explanations was interpreted to provide a deeper understanding of
the MIDI questionnaire findings and additional insights and nuances on overcoming barriers and
leveraging facilitators for the KT strategy. At the end of this phase, a set of recommendations
tailored to each participating country was elicited for implementing and disseminating the
NeuroAdvocacy Toolkit.
Limitations
Some of the study limitations included potential threats to internal and external validity.
The first threat to internal validity was the lack of a comparison group; therefore, other events
occurring within the study's timeframe may have generated the observed results (Portney, 2020).
In this case, using a single group was justified because the study did not have an experimental
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manipulation. Instead, participants were approached in their natural setting. Finally, the results of
this study are generalizable only to Latin American countries due to their unique social, cultural,
and political reality.
There were also threats to trustworthiness, such as the risk of researcher bias for the
investigator being part of the strategy as a researcher and, simultaneously, an advocate
participating in policy dissemination. Therefore, it was essential not to consider the researcher’s
influence as a problem but to understand it and use it productively (Maxwell, 2012). Bracketing
procedures helped in mitigating this threat. Besides, there was a potential risk for KOL’s reactivity
affecting their responses due to their awareness of being part of a study. However, reactivity
facilitated a deeper understanding of the phenomena studied and more relevant and actionable
findings. The use of multiple methods for data collection allowed for controlling threats to
trustworthiness through triangulation, complementarity, and expansion procedures.
Finally, since the surveys and interviews were conducted in Spanish and all data were
translated back into English, there was a possibility of confusion, ambiguities, or errors arising
from the nuances of language. Back translation and reconciliation procedures were carried out to
ensure quality, accuracy, and equivalence of meaning between the participants' answers and target
texts.
Definition of Key Terms
Neural tube defects
NTDs are a group of congenital malformations caused by incomplete closure of the neural
tube during the early stages of embryonic development at the primary neurulation stage (O’Rahilly
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& Müller, 2001). NTDs include anencephaly, iniencephaly, craniorachischisis, encephalocele,
spina bifida aperta, spina bifida occulta, and other types of spinal dysraphism.
Food fortification
Food fortification practices deliberately increase the content of essential micronutrients,
i.e., vitamins and minerals (including trace elements), to improve the food supply's nutritional
quality and provide a public health benefit with minimal risk to health (Allen et al., 2006).
Mandatory food fortification
Mandatory food fortification (MFF) is a regulation that requires food manufacturers to add
specific vitamins (such as folic acid) or minerals, or both, to specified foods to address a significant
public health need (CDC, 2020a).
Evidence-based intervention
Evidence-based interventions include programs, practices, processes, policies, or
guidelines whose efficacy and effectiveness have been proven or informed by research and
evaluation (National Center for Healthy Safe Children, 2020; Rabin et al., 2008).
Evidence-based policy
Evidence-based policies are public health actions informed by scientific evidence, but the
decisions will depend on prevailing values and priorities. The decision-making process often
requires the interplay of advocacy, lobbying, and more complex social and political negotiations
than only appraising evidence and formulating recommendations (Rychetnik et al., 2004). MFF
with folic acid is an example of an evidence-based policy aimed at preventing NTDs.
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Knowledge translation (KT)
KT is a dynamic and iterative process that includes the synthesis, dissemination, exchange,
and ethically sound application of knowledge to improve health, provide more effective health
services and products and strengthen the healthcare system (CIHR, 2020; Straus et al., 2011).
Knowledge translation strategy
A KT strategy aims to increase awareness and utilization of research evidence in health,
including printed educational materials, educational meetings, educational outreach, local opinion
leaders, audit and feedback, and reminders (Barac et al., 2014).
Local opinion leaders
Also known as key opinion leaders (KOL). In the health sciences field, they are “health
professionals nominated by their colleagues as educationally influential” (O’Brien et al., 1999).
MIDI questionnaire
The Measurement Instrument for Determinants of Innovations (MIDI) is an instrument
that maps the determinants that influence the use of innovation in practice (Fleuren et al., 2014).
It was the selected instrument to gather data in the quantitative phase of this study.
Public health intervention
Public health interventions are actions or programs applied to multiple members in a
community aiming to produce identifiable outcomes that can deliver a net benefit to the population
and individuals. Public health interventions include policies of governments and non-government
organizations, laws/regulations, organizational development, community development, education
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of individuals and communities, engineering and technical developments, service development
and delivery, communication, and social marketing (Rychetnik et al., 2004).
Regulation
A regulation broadly implies the imposition of government rules backed by the use of
penalties specifically intended to modify the economic behavior of individuals and firms in the
private sector to enforce compliance with higher-order norms that affect the population at large
(OECD, 2008). Regulations can include laws, decrees, resolutions, policies, and norms.
Throughout this dissertation, the terms regulation, legislation, and policies might have been used
interchangeably to refer to mandatory food fortification rules promulgated, enacted, and enforced
by state authorities.
Stakeholder
Stakeholders are individuals or groups responsible for or affected by health- and
healthcare-related decisions that can be informed by research evidence (Concannon et al., 2014).
Stakeholder engagement
In research, stakeholder engagement entails “a bi-directional relationship between
stakeholder and researcher that results in informed decision-making about the prioritization,
conduct, and use of research” (Concannon et al., 2014).
Toolkit
A toolkit is a type of KT strategy consisting of the packaging of multiple resources that
codify explicit knowledge, templates, pocket cards, guidelines, algorithms, and summaries geared
to share knowledge, educate, or facilitate behavior change (Barac et al., 2014). Toolkits result from
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multifaceted combinations of sources such as guidelines for practice, audio-visual materials, and
electronic publications. They communicate messages aimed at improving health and changing
practices to diverse audiences, including healthcare practitioners, patients, community and health
organizations, and policymakers (Barac et al., 2014). The core innovation of this research study is
the NeuroAdvocacy Toolkit.
Translational research continuum

The translational process, also known as the translational spectrum, is a continuum of
knowledge, processes, skills, and practice reflected by clinical and translational science, whose
amalgamation and integration are essential to the successful application of new scientific
discoveries to the creation of community wellness (Waldman & Terzic, 2010). The continuum is
constituted by five moments or steps. T0 includes preclinical and foundational research that
informs research with humans. T1 involves translation to humans through clinical interventions
and initial settings, including proof of concept studies and phase I and II clinical trials. T2 implies
translation to clinical settings to inform evidence-based guidelines, including phase III trials. T3
involves translation to practice and implementation in real-world settings, including phase IV trials
and clinical practice guidelines. T4 implies translation to populations associated with improved
disease prevention and reduced costs for medical care, including population-based outcome
studies. The present study intends to bridge the chasm between the T3 and T4 moments of the
continuum. Finally, T5 involves translating the population-based effects to the policies derived
from it, including social healthcare, macroeconomics, and political measures for access to
healthcare and education (Waldman & Terzic, 2010).
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Translational science
The field of investigation focused on understanding the scientific and operational principles
underlying each step of the translational process (NCATS, 2020).
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Chapter 2: Literature Review
NTDs are a set of severe congenital malformations of the central nervous system due to an
absent, incomplete, or impaired closure of the neural tube in the embryonic stage, leading to
significant neurological deficits, disability, and related complications in patients affected with
these conditions (Greene et al., 2014). NTDs constitute a substantial cause of pregnancy
termination, stillbirths, mortality, morbidity, and long-term disability. Annually, up to three of
every 1,000 children can be born with an NTD, including anencephaly or spina bifida, with a
global estimated rate of 300,000 new cases per year (Blencowe et al., 2018; Zaganjor et al., 2016).
In more than 70% of the cases, the cause is a maternal folic acid deficiency or insufficiency (FFI,
2022). However, other risk factors have been identified, including gestational diabetes, genetic
abnormalities, and teratogenic exposure to medications and other physical or chemical agents
(Mitchell, 2005).
Despite substantial efforts to understand the genetics, pathophysiology, and surgical
treatment of NTDs, the natural history of these conditions continues to exhibit high morbidity and
marked impairment of the quality of life of affected patients (Estevez-Ordonez et al., 2018). Except
for children with lethal malformations, patients with NTDs can undergo successful corrective
surgery after birth, or during the intrauterine stage, in countries with installed healthcare capacity
to perform such procedures. Notwithstanding, and despite successful neurosurgical treatments,
these patients might face different long-term health issues in physical, cognitive, psychological,
and social areas, leading them to require additional surgeries and several treatments and aids during
their lifetime. Furthermore, the calculated direct and indirect costs of care for individuals with
NTDs are enormous, which ensures profound inequities and disparities in disease burden,
especially for low and middle-income countries (Estevez-Ordonez et al., 2018).
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With this landscape, the ideal scenario is the primary prevention of NTDs. Mandatory food
fortification is a successful public health evidence-based policy to prevent folic acid-sensitive
NTDs, which has been available for several decades (Crider et al., 2011). Globally, MFF of cereal
grains is only implemented in about 60 countries, preventing nearly 62,000 cases of all preventable
NTDs as of the year 2020, and accounting for only 22% of the NTDs that could be prevented;
there are an additional 200,000 preventable cases in more than 100 countries that do not implement
MFF with folic acid (Kancherla, Wagh, et al., 2022). As a public health intervention, scientific
evidence has shown that food fortification is a practical, safe, feasible, and cost-effective policy.
It also decreases costs associated with healthcare and helps countries achieve their sustainable
development goals (Hoddinott, 2018; Högler et al., 2016; Kancherla, Roos, et al., 2022). Despite
these facts, only 92 countries worldwide have adopted a mandatory fortification policy for cereal
grains. From those, only 63 countries include folic acid in their fortification standard, and the
majority focus solely on one staple food, wheat flour (FFI, 2022; Kancherla, Botto, et al., 2022).
Many women of reproductive age are vulnerable across the globe as they do not use enriched
wheat flour and its derivates as an ingredient in their regular diet or traditional recipes, such as
corn masa (Heather C. Hamner et al., 2011; Marchetta et al., 2015; Marchetta & Hamner, 2016;
Minsalud Colombia, 2015). This situation hinders the protection of many children from these
devastating but preventable conditions.
Purpose
This literature review aimed to synthesize the relevant scientific publications about NTDs,
their relation to folic acid levels, and the main preventive measures, including policies for food
fortification. It also aimed to identify the barriers and facilitators to implementing those policies,
the role of neurosurgical advocacy, and the gaps that future research could address to advance in
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translating knowledge to decision-makers willing to protect thousands of children from these
congenital anomalies.
Methods
The search strategy covered PubMed, Scopus, CINAHL, and SciELO databases; grey
literature sources such as Open Grey and Pro-Quest; and repositories from the Centers for Disease
Control (CDC), the World Health Organization (WHO), and the Food Fortification Initiative (FFI).
The search had no language or publication type restrictions and covered the timeframe between
1980, when the first publications on the relationship between nutritional deficiencies and NTDs
started to appear, and 2022. It included the following key terms: neural tube defects, folic acid,
food fortification, culture and beliefs, health legislation, barriers and facilitators, implementation,
public health intervention, evidence-based policy, knowledge translation, global neurosurgery, and
advocacy.
This literature review reflects a body of knowledge built from disciplines such as medicine,
neurosurgery, nutrition, pediatrics, obstetrics, public health, and epidemiology. It provides a
comprehensive overview of the strategies to decrease the impact of NTDs as disabling conditions
and their controversial aspects.
Description and Critique of Scholarly Literature
Neural tube defects: General aspects
NTDs are a group of congenital malformations caused by incomplete closure of the neural
tube during the early stages of embryonic development at the primary neurulation stage, usually
between the 23rd and 26th day following conception (O’Rahilly & Müller, 2001). NTDs can be
classified as open if neural tissue is exposed or covered only by a membrane and closed if healthy
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skin covers the defect. According to etiopathogenesis, these congenital malformations can be folic
acid-sensitive NTDs caused by maternal folate insufficiency and folic acid-resistant NTDs, when
the malformation does not relate to folic acid insufficiency. NTDs include anencephaly,
iniencephaly, craniorachischisis, encephalocele, spina bifida aperta, spina bifida occulta, and other
types of spinal dysraphism. These congenital anomalies are defined as follows:
Anencephaly. This severe and fatal NTD consists of the absence of a significant portion
of the brain, skull, and scalp that occurs during embryonic development (O’Rahilly & Müller,
2001).
Craniorachischisis. This extremely severe and invariably fatal NTD is due to complete
primary neurulation failure no later than 20–22 days after conception. It consists of anencephaly
and a contiguous and complete bony defect of the spine with exposure to neural tissue (Naveen et
al., 2010; Polat et al., 2005).
Encephalocele. This late neurulation defect occurs during the 4th gestational week,
consisting of a midline protrusion of cranial contents outside the skull. This defect is due to a
disturbance in the separation of the surface ectoderm (epithelial layer) from the neurectoderm
(nervous tissue) just after the closure of the neural folds. The internal skull defect usually locates
in the midline. In contrast, the external skull defect may vary with the bony surroundings of the
defect in the scalp or the facial skeleton, leading to topographic classification in occipital, cranial
vault, frontoethmoidal, and basal encephaloceles (Hoving, 2000).
Iniencephaly. This severe and almost uniformly fatal NTD consists of a variable deficit of
the occipital bones, resulting in an enlarged foramen magnum; a partial or total absence of cervical
and thoracic vertebrae; abnormal vertebral fusion accompanied by incomplete closure of the
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vertebral arches or bodies; significant shortening of the spinal column due to marked lordosis and
hyperextension of the malformed cervicothoracic spine; and an upward-turned face and
mandibular skin directly continuous with that of the chest due to the lack of neck (C. P. Chen,
2007).
Spina bifida aperta. It is also known as open spina bifida, spina bifida cystica, or cystic
spina bifida. In this NTD, an open bony defect of the posterior vertebral arches leads to herniation
of neural tissue and meninges (Naveen et al., 2010). The two forms of cystic spina bifida are
meningocele and myelomeningocele, which can occur at any level of the vertebral column but are
more common in the lumbar and sacral areas. A meningocele is a saccular herniation of meninges
and cerebrospinal fluid through a bony defect of the spine, usually covered by healthy skin.
Myelomeningocele (MMC) is the most common type of spina bifida; it is characterized by
herniation of the spinal cord, nerves, or both through a bony defect of the spine (Naveen et al.,
2010).
Spina bifida occulta. It is also known as closed spina bifida. In this type of spinal
dysraphism, a defective closure of the neural tube causes a set of ‘covered’ spinal cord lesions that
include lipomyelomeningocele, split cord malformation (diastematomyelia), meningocele
manqué, ectodermal inclusion tumor or cyst, dermal sinus tract, neurenteric cyst, and tight filum
terminale. These lesions are often concealed or occult and may be asymptomatic, therefore
detected later in life; however, in the majority of cases, cutaneous (hypertrichosis, capillary
hemangioma, subcutaneous lipoma, dermal sinus, caudal appendage, atretic meningocele) and
orthopedic (vertebral or lower extremity anomalies) stigmata exist, allowing early diagnosis
(Lapsiwala & Iskandar, 2004).
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Pathophysiology of NTD and the role of folic acid in neural tube closure
Closure of the neural tube is a crucial process of embryogenesis during the third and fourth
weeks of gestation when most women are usually unaware that they are pregnant. A harmonic
closure promotes the healthy development of the central and peripheral nervous systems (Blom,
2013). Failure of this process can result in NTDs, which have a multifactorial etiology with the
interplay of genetic and environmental factors. Even though chromosomal and single-gene
disorders are among the genetic factors related to NTDs, the inheritance pattern favors a
multifactorial polygenic or oligogenic model, as opposed to an effect of single genes with partial
penetrance (Harris & Juriloff, 2007). Meanwhile, environmental factors are related to seasonal
changes, geographical areas, and socioeconomic status (Blom, 2013). On the other hand, some
parental conditions constitute specific risk factors for NTDs, such as gestational diabetes, maternal
obesity, maternal use of antiepileptic drugs such as valproic acid, maternal hyperthermia, and
paternal occupational exposure (Agopian et al., 2013; Blom, 2013; Greene et al., 2014).
Undoubtedly, the leading risk factor in developing an NTD is diminished folate status
(Bailey & Hausman, 2018). Folate is a general term used to describe the many different forms of
water-soluble vitamin B9, including folic acid, dihydrofolate (DHF), tetrahydrofolate (THF), 5,
10-methylenetetrahydrofolate (5, 10-MTHF), and 5-methyltetrahydrofolate (5-MTHF) (Crider et
al., 2011). The primary form of folate circulating in the blood is 5-methyl tetrahydrofolate (5methyl-THF); therefore, it is the standard form of measuring and reporting serum folate levels
(Choi et al., 2006). On the other hand, folic acid is the synthetic form of folate used in supplements
and fortified foods as it is more stable during storage and processing, including cooking or baking
(Choi et al., 2006). After ingestion and absorption, folic acid is easily converted to folate,
increasing serum folate concentrations across populations (CDC, 2020a).
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Serum folate deficiency, also known as vitamin B9 deficiency, is a low level of folate and
derivatives in the body, below the range of 7 nmol/L for serum folate and <227 nmol/L for red
blood cells folate, usually due to inadequate dietary intake or absorption; however, it can also be
caused by increased folate needs or increased excretion or loses. Serum folate deficiency has been
associated with NTDs, megaloblastic anemia, and chronic disease risk (Darnton-Hill, 2019).
Moreover, the folate concentration needed to support rapid cell division at the neural tube closure
is much higher; therefore, it requires a higher cut-off (<25.5 nmol/L for serum folate and <748906 nmol/L for red blood cells folate) to provide maximum protection against folate-dependent
NTDs (Chen et al., 2019). Folate levels below this cut-off are referred to as folate insufficiency.
At the population level, red blood cell folate concentrations (a better marker of the long-term folate
status of an individual) should be above 400 ng/mL (906 nmol/L) in women of reproductive age
to achieve the most significant reduction of NTDs (CDC, 2022).
The underlying mechanisms by which folate deficiency or insufficiency induces NTDs
have been associated with impairment of cell division due to genetic variations in folate transport
and metabolism, as well as the presence of autoantibodies against the folate receptor, leading to a
maternal immunological response impeding folate uptake (Osterhues et al., 2013).
Because of the failed neural tube closure in the embryo, the neural tissue endures prolonged
exposure to the amniotic fluid environment. The neuroepithelium initially presents relatively
normal neuronal differentiation, with the development of spinal motor and sensory function above
and below the lesion level. As gestation progresses, the exposed spinal cord becomes hemorrhagic.
Neurons die due to the toxicity of the amniotic fluid, leading to axonal disconnections and loss of
function (Copp et al., 2015).
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Clinical manifestations
Infants born with NTDs can present various clinical manifestations and health concerns
throughout their lives, including physical, cognitive, emotional, and social issues. Physical
problems include hydrocephalus, craniovertebral junction anomalies such as Chiari malformation,
tethered cord, spinal deformities such as scoliosis and kyphosis, bladder or bowel incontinence,
limb deformities, and inability to walk (Copp et al., 2015). Cognitive issues include intellectual
disabilities, although infrequent, and difficulties in learning to construct and assimilate information
(Taylor et al., 2013). On the other hand, psychological complaints include a higher incidence of
depressive symptoms and lower self-esteem (Copp et al., 2015). Meanwhile, social issues involve
family dysfunction (Holmbeck et al., 2006), less social interaction, more dependent behaviors, and
decreased autonomy (Friedman et al., 2009).
Treatment
Craniorachischisis, anencephaly, and iniencephaly are extremely severe NTDs
incompatible with prolonged extrauterine life, usually leading to stillbirths or pregnancy
terminations. Therefore, conservative treatment or palliative measures are the standard of care for
the affected neonates born alive. On the other hand, surgical treatment is the gold standard for
encephaloceles, spina bifida aperta, and many cases of spina bifida occulta. Different neurosurgical
techniques can successfully correct these birth anomalies and prevent the complications associated
with untreated NTDs. They include prenatal or postnatal repair of MMC, treatment of associated
hydrocephalus, posterior fossa decompression of the Chiari type II malformation, encephalocele
correction, lipomyelomeningocele repair, and cord untethering (Estevez-Ordonez et al., 2018).
Most cases of spina bifida occulta are asymptomatic; if they remain like that, they usually benefit
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from conservative management and close routine follow-up. Surgical indications for spina bifida
occulta include intractable spine or limb pain, progressive spinal deformity associated with
tethered cord, worsening neurogenic bladder and bowel, and symptomatic Chiari. Despite
successful surgeries for correcting NTDs, the prevalence of long-term complications and disability
remains high; therefore, prevention efforts are essential to decrease the rate of these congenital
anomalies and their consequences.
Strategies to prevent neural tube defects
Multilevel prevention strategies can be combined to decrease the prevalence of NTDs.
Figure 2.1 summarizes the main strategies addressing different etiologic conditions and
illustrates the interconnectivity and complementarity of preventive measures since they are not
mutually exclusive. This dissertation focuses on folate deficiency or insufficiency primary
prevention strategies at the public policy level.
Figure 2. 1 Multilevel strategy for prevention of neural tube defects
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Note: Ghotme, own work, created with SmartArt

Folic acid supplementation. Dietary supplements are oral products that contain a dietary
ingredient meant to supplement nutrients in the diet (CDC, 2020a). Folic acid supplementation is
explicitly the act of taking a supplement that contains folic acid, usually in the form of a vitamin
pill, every day (CDC, 2020a).
The literature synthesized in a Cochrane review shows a protective effect of daily folic acid
supplementation (alone or in combination with other vitamins and minerals) in preventing NTDs
compared with no interventions/placebo or vitamins and minerals without folic acid (De-Regil et
al., 2015). Supplementation may also reduce other congenital malformations such as cleft lip, cleft
palate, and congenital cardiovascular defects. Supplementation with folic acid is recommended
globally for women before conception until the first trimester. WHO also recommends that women
of reproductive age take intermittent iron and folic acid supplements, especially in populations
with a prevalence of anemia above 20% (De-Regil et al., 2015). Nevertheless, these
supplementation strategies do not significantly impact public health since less than 4% of the
population takes vitamin supplements, and less than half of the pregnancies are planned and get
access to preconception assessment and counseling (Ray et al., 2004).
Food fortification initiatives. Food fortification is the practice of deliberately increasing
the content of an essential micronutrient, i.e., vitamins and minerals (including trace elements) in
food, to improve the nutritional quality of the food supply and to provide a public health benefit
with minimal risk to health (Allen et al., 2006). Folic acid fortification is a specific process by
which synthetic folic acid is added to staples, aiming to increase the blood folate levels in the
population (CDC, 2020a). As a public health measure, this process can be mandatory or voluntary.
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Mandatory food fortification (MFF) is a regulation that requires food manufacturers to add specific
vitamins (such as folic acid) or minerals, or both, to specified foods to address a significant public
health need (CDC, 2020a). In contrast, voluntary food fortification is a process that allows food
manufacturers to choose what vitamins and minerals they add to food as long as they abide by the
regulations established in each country (Food Standards, 2020).
Scientific evidence supporting food fortification. A substantial body of evidence supports
that regulations that enforce mandatory folic acid fortification of one or more grain cereals and
their derivates induce a significant decrease in the incidence of NTDs and their associated
morbidity and mortality (Atta et al., 2016; Garrett & Bailey, 2018; Kancherla et al., 2014). As an
evidence-based policy, MFF is practical since it does not require women to change behaviors (such
as taking supplements) to improve their periconceptional folate status (Martinez et al., 2018, 2021;
Pachón et al., 2013). It is also safe, given that programs implemented in many countries have no
adverse consequences (Field et al., 2018). MFF is feasible since over a hundred countries already
have mandatory fortification with micronutrients of different foods, including maize flour (19
countries), oil (34 countries), rice: (8 countries), salt (126 countries), and wheat flour (91 countries)
(Global Fortification Data Exchange, 2022). It is also feasible because countries with existing
industrial milling infrastructure can immediately fortify staple foods and prevent more than 50,000
cases annually (Kancherla, 2018). Last, and most importantly, it is cost-effective because
fortifying food is inexpensive and saves lives and millions in resources and efforts (CDC, 2020b).
Controversial evidence against food fortification. Despite MFF being a groundbreaking
public health intervention to prevent NTDs, other congenital disabilities, and several noncongenital health issues, there are reports of potential risks; however, they have been refuted with
solid scientific evidence. Excessive folic acid intake may mask a vitamin B12 deficiency,
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potentially resulting in neurologic damage (Mills, 2017). However, the available evidence
indicates that folic acid intakes of up to 1 mg/day, the adult upper level of intake, will not mask
the diagnosis of vitamin B12 deficiency (Berry, 2019). At the same time, the upper level’s
relevance for younger age groups, particularly children, is unclear because vitamin B12 deficiency
is rare in the pediatric population (Mills, 2017). Moreover, Wald et al. and Pachon et al. have stated
that there is no scientific basis for setting an upper level of intake for folate and proposed that the
upper level should be eliminated since it acts as a barrier to large-scale fortification (Pachón et al.,
2021; Wald et al., 2018).
Although there is the potential for increased folic acid intake to interfere with certain
medications, the available scientific evidence does not demonstrate any clinically significant
interaction with therapeutic medicines from folate intakes up to 1 mg/day (Choi et al., 2006).
One source of resistance to MFF policies is the belief that they limit consumers’ choice
regarding opting for non-fortified products; however, this is not the main issue in many low and
middle-income countries, where poverty remains the limiting factor to access processed foods for
most of the population (Allen et al., 2006).
Global situation of MFF policies. Only 92 countries in the world (47%) have regulations
that enforce MFF of cereal grains with micronutrients (Figure 2.2), primarily focused on wheat
flour and its derivates (FFI, 2022); from those, just about 63 countries include folic acid in the
fortification policy. Even though the existing industrial milling infrastructure provides the
immediate potential to fortify wheat flour in another 71 countries and, thus, prevent 57,000
additional cases of congenital anomalies of the brain and spine annually (Kancherla, 2018), many
countries in Africa, Asia, Europe, and Oceania do not implement fortification of staples with folic
acid.
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Figure 2. 2 World map illustrating mandatory micronutrient fortification status for wheat flour,
maize flour, and rice

Note: Used with permission from the Food Fortification Initiative (FFI, 2022).

Only three countries in Europe (Moldova and Kosovo, and more recently, the United
Kingdom) have embraced mandatory folic acid fortification (DEFRA, 2021; FFI, 2022; Global
Fortification Data Exchange, 2022), resulting in more than a thousand pregnancies affected by
preventable spina bifida and anencephaly every year in that continent (Kancherla, Botto, et al.,
2022). The reasons for the endurance of this prevalence are multifactorial. For instance, a study
conducted in Italy addressed the transition in dietary habits affecting the Mediterranean diet,
previously shown to be protective against NTDs, to a more “North American” diet as one potential
cause for this phenomenon (Fischer et al., 2017). On the other hand, increasing migration of people
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from African countries and Eastern Europe could have also changed the landscape of dietary habits
and access to quality food in some communities living in Southern Europe. Fisher et al. argue that
folic acid supplements alone are not enough to decrease the incidence of NTDs; therefore, efforts
for food fortification, among others, are needed (Fischer et al., 2017). In 2021, the United Kingdom
mandated adding folic acid to wheat flour, which was previously fortified with other
micronutrients. However, the amount of folic acid is still being stipulated (DEFRA, 2021).
In 2021, the International Society for Pediatric Neurosurgery (ISPN) recommended that all
governments enact policies for MFF with folic acid of centrally produced staples to provide almost
all women of reproductive age who eat fortified foods with at least an additional 150 μg/day of
folic acid, according to the WHO recommended guidelines (Caceres et al., 2021).
In a global context, despite countries having existing policies for fortification of cereal
grains with folic acid, most of them focus only on one staple (mainly wheat flour) (FFI, 2022),
leaving groups of people who favor other food sources (such as maize flour or rice) in their diet
without the benefit of getting folic acid-enriched products. In some regions, vulnerable
communities do not access industrially-processed, fortified wheat flour and derivate products
(Hamner et al., 2011; Marchetta et al., 2015; Sarah C. Tinker et al., 2012) and base their diet on
rice, corn masa, yucca (cassava), teff, or quinoa for geographic, historical, cultural, or ethnic
reasons or because those grains constitute the only staple. Therefore, those countries with existing
policies can benefit from updating and scaling up MFF policies to include other staples with the
recommended guidelines for folic acid while optimizing surveillance and ensuring the
sustainability of existing policies.
Most countries with MFF policies in place have systems for surveilling implementation.
However, documentation of compliance with those policies, the roles and responsibilities between
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agencies, the cost of regulating fortification, and enforcement strategies, are often lacking (Marks
et al., 2018).
Partnerships joining efforts from multiple stakeholders are crucial since they combine
diverse expertise and perspectives. The Global Alliance for the Prevention of Spina Bifida F
(GAPSBiF), a multidisciplinary coalition of neurosurgeons, pediatricians, geneticists,
epidemiologists, food scientists, and fortification policy experts, was formed to advocate for MFF
of staple foods worldwide (Shlobin, Roach, et al., 2022).
A recent call to action from the scientific community led by GAPSBiF, published in The
Lancet Global Health, urges the World Health Assembly to pass a resolution for universal
mandatory folic acid fortification (Kancherla, Botto, et al., 2022). Such a resolution could
accelerate the slow pace of NTD prevention globally and assist countries in reaching their 2030
Sustainable Development Goals on decreasing child mortality and promoting health equity. The
cost of inaction is profound and disproportionately impacts susceptible populations worldwide,
with a more significant impact in low-income and middle-income countries.
MFF regulation in Latin America. Latin America is the term used to describe the 20
independent republics in North, South, and Central America that speak Romance languages, after
being colonized by the Latin nations Spain, Portugal, and France. Latin America consists of 20
countries (Figure 2.3) and 14 dependent territories, covering approximately 19,197,000 km2
(7,412,000 sq. mi). The region spans from Mexico to Tierra del Fuego and includes much of the
Caribbean, constituting almost 13% of the Earth’s land surface area. As of the first half of 2022,
the estimated population of Latin America and the Caribbean was more than 656 million, with a
combined nominal GDP of US$5,188,250 million and a GDP PPP of 10,284,588 million USD in
2019 (Latin America - Wikipedia, 2022).
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Figure 2. 3 Latin American region

Note. Pertaining countries colored in blue, by Ghotme - Own work, created with mapchart.net
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In a scientific meeting held in Bolivia in 2006, the Latin American Association for Pediatric
Neurosurgery (ASOLANPED) promulgated the Declaration of Santa Cruz. This document
reinforces that the high incidence of NTDs in Latin American countries is a social problem
preventable by implementing MFF. The declaration also recommended that the region’s
governments support this policy and consider other environmental factors that could be related to
NTDs in the specific Latin American context (Dabdoub et al., 2014). However, the Declaration of
Santa Cruz did not provide detailed guidance on how to translate the evidence to influence
government agents’ support of the policy.
Meanwhile, Latin American countries have made meaningful progress in public health
policies regarding MFF and the prevention of NTD. Table 2.1 crosses data from three sources
(FFI, 2022; Rosenthal et al., 2014; Zaganjor et al., 2016) that report the existence of legislation for
MFF in Latin American countries and their prevalence of NTDs. It shows that the presence of
MFF regulatory acts is almost uniform in the region for wheat flour. In contrast, it is incomplete
(for instance, not including folic acid in the fortification standard or adding folic acid
concentrations below the recommended guidelines), in some cases voluntary, and often null for
maize (corn) and rice, two essential staple foods in the diet of millions of Latin Americans. The
fortification status correlates directly with a decreasing NTD prevalence in some countries with
more robust fortification policies while remaining persistently high in others, especially those with
incomplete fortification status (only one staple food fortified or current fortification below the
recommended guidelines). It is noteworthy that Costa Rica exhibits positive deviance since this
country has successfully implemented policies on MFF of the three main staple foods, which has
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led to the minimum level of NTDs reported when a successful strategy for folic acid fortification
is applied.

Table 2. 1 Type of fortification legislation and neural tube defects (NTDs) prevalence in Latin
American countries

COUNTRY
Argentina
Bolivia
Brazil
Chile
Colombia
Costa Rica
Cuba
Dominican
Republic
Ecuador
El Salvador
Guatemala
Haiti
Honduras
Mexico
Nicaragua
Panama
Paraguay
Peru
Uruguay
Venezuela

LEGISLATION FOR FOOD
FORTIFICATION
WHEAT MAIZE
RICE
FLOUR FLOUR
Mandatory
None
None
Mandatory
None
None
Mandatory Mandatory
None
Mandatory
None
None
Mandatory
None
None
Mandatory Mandatory Mandatory
Mandatory
None
None
Mandatory Voluntary
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory
Mandatory

None

None
None
Mandatory
None
Mandatory
None
None
None
None
None
Mandatory
None
None
Mandatory
None
Mandatory
None
None
None
Voluntary
None
None
Mandatory Voluntary

PREVALENCE
OF NTDs PER
10,000 BIRTHS
11.9
11
24.3
10.1
11
4.8
10
11
8
8
27.9
18
17.4
11
8
8
8
20
17.5
17

Note. Ghotme – own work, based on Food Fortification Initiative, 2022; Global Fortification Data
Exchange, Kancherla, 2022; Zaganjor et al., 2016; and Rosenthal et al., 2013. Although Puerto
Rico is considered part of Latin America, it was excluded from this table since the regulations for
fortification are under the United States legislation. NTDs: Neural tube defects.
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Barriers and facilitators to the implementation of MFF as an evidence-based policy
Evidence-based policies are public health actions informed by a consideration of the
scientific evidence, but the decisions made will depend on determinant factors and prevailing
values and priorities; therefore, this process often requires the interplay of advocacy, lobbying,
and more complex social and political negotiations, than only appraising evidence and formulating
recommendations (Rychetnik et al., 2004).
The literature points to different determinant factors acting as barriers or facilitators for the
reach, adoption, implementation, and scaling-up of MFF with micronutrients, including folic acid,
as an evidence-based policy. They comprise individual and contextual factors, internal or external,
that may vary according to specific circumstances. However, there is scarce information in the
literature regarding theories, models, frameworks, or knowledge translation interventions that
address how to overcome those barriers or leverage the facilitators to effectively and successfully
implement MFF to prevent NTDs.
Barriers. Table 2.2 summarizes the main barriers to the implementation of MFF policies.
Despite substantial evidence of the efficacy and effectiveness of MFF as a successful public health
intervention, one of the evident barriers in the literature is a lack of willingness from local
authorities in many countries to either enact regulations for this evidence based-policy or to
provide sufficient oversight to ensure that industry and importers follow the rules for mandatory
folic acid fortification (Estevez-Ordonez et al., 2018; Martin et al., 2011; Mills, 2017). One
potential reason for that is the concern that exposure to high doses of folic acid might cause an
increased risk of different disorders. Other aspects, including perceived costs of fortification by
the food industry and socio-political reasons, might also play a role.
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Higher than normal serum folate levels have been associated with health issues such as
cancer, asthma, cognitive problems, twin pregnancy, and autism and may mask vitamin B12
deficiency (Fischer et al., 2017). However, scientific evidence does not confirm these risks (Berry,
2019; Wald et al., 2018). Although masking of vitamin B12 deficiency in older adults with
macrocytic anemia has been described if they are only treated with folate and not folic acid (Mills,
2017), in modern practice, it is unlikely that vitamin B12 deficiency masking would happen (Berry,
2019). Moreover, the evidence points in the opposite direction since no singular study has enough
level of evidence to recommend against food fortification on a massive scale. For instance, a rare
condition causes slow processing of folates (Crider et al., 2011). However, it does not lead to toxic
serum folate levels in individuals receiving folic acid supplements at the recommended doses since
folic acid is a water-soluble vitamin excreted in the urine when it reaches excessive serum
concentration.
The ambiguous role of synthetic folic acid in promoting subclinical cancers, mainly
colorectal cancer, has led to the hesitation of some countries, mainly in Europe, to introduce a
public health intervention for MFF (Smith et al., 2008). Nevertheless, the increased incidence of
colorectal cancer is more attributable to improved screening for that type of cancer. Quite the
opposite, there is evidence of a protective effect for pancreatic cancer with increasing dietary folate
intake (Jägerstad, 2012). Additionally, one study discusses folic acid fortification’s role in a higher
risk of malaria in African countries (Nzila et al., 2016). However, this finding has been
controversial since folic acid supplements usually contain iron, whose high levels reportedly
increase the risk of malaria; meanwhile, other studies have shown a protective effect of folates
against that parasitic illness. The authors propose a dose-dependent effect, whereby intake of low
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doses of folic acid (which corresponds to the daily intake from food fortification) would have a
marginal impact on malaria disease.
Different dietary habits rooted in local or national cultures may also act as barriers leading
to a low reach of MFF as an impactful measure to prevent NTDs. For instance, Mexican American
women, a vulnerable immigrant population in the United States whose offspring have a high
incidence of NTDs, rely on non-fortified products such as corn masa as the main component of
their traditional recipes (Hamner et al., 2011). This cultural practice, along with other potential
factors such as race/ethnicity and acculturation, is associated with lower folate intake and low
serum-folate levels among women of reproductive age in that group (Hamner et al., 2011;
Marchetta & Hamner, 2016). Hence, the fortification of wheat flour has a weak influence on these
communities since the basis of their dietary habits does not include wheat flour products but other
non-fortified cereal grains such as non-fortified maize flour, a common ingredient in corn masa
and other traditional recipes made with locally grown or imported grains. In that sense, studies
modeling fortification of traditional foods like corn masa found a positive potential to selectively
increase total folic acid intake among Mexican-American women without exceeding the tolerable
upper intake level for folic acid (Hamner et al., 2013; Tinker et al., 2012).
Table 2. 2 Critical determinant factors acting as barriers and facilitators to adopt mandatory
food fortification policies
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Barriers
Lack of translational knowledge by
coordinating level officials
Concerns on potential adverse effects of
high level intakes of folic acid

Type of factor

Individual

Bureaucratic processes delay adoption
and enactment of policies
Focus in wheat flour and neglect of other
food sources or traditional foods

Contextual

Race/ethnicity, acculturation of immigrant
groups
Lack of willingness from local authorities
to adopt folic acid fortification as a public
health measure in some countries
Influence of food importers, for their nonfortified products to enter countries, in
virtue of free trade agreements (FTAs)

Facilitators
Advocacy/leadership of physicians and
professional organizations to broker
knowledge to policymakers
Established infrastructure of milling
industry in many countries with potential
for immediate fortification
Commitment and willingness of local
milling industry to adopt fortification
policies, since they see it as part of their
social liability
Interdisciplinary approaches and modelling
of fortification of traditional foods
Influence of supranational organizations on
regional and local law/policy makers

External
Private/public partnerships (industry,
government, academia, and civil society)

Note. Based on a scoping review (Ghotme, 2018)

Facilitators. The literature also suggests facilitators for the implementation of MFF
policies, summarized in Table 2.2. One of the facilitators is the existing milling infrastructure,
which creates a potential for immediate fortification in many countries (Kancherla, 2018). Also,
supranational policies encourage local governments to achieve Sustainable Development Goals by
2030, including ending hunger and improving the population's health status, as is the case for
preventing NTDs (Kancherla et al., 2019). On the other hand, private/public partnerships, adequate
monitoring, and quality control are among the main components of successful staple food
fortification programs in Latin America. They might also be critical elements for the sustainability
of those programs (Martorell & de Romaña, 2017).
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The role of Global Neurosurgery in neurosurgical advocacy
Neurosurgical conditions are usually devastating, and their care is highly demanding in
terms of costs and effort. However, the involvement of neurosurgeons in public health initiatives
is scarce. Their participation, advocacy, and lobbying can be impactful in promoting evidencebased policies and integrating the neurosurgical burden into national health planning systems
(Veerappan et al., 2022).
Global neurosurgery is an “area of study, research, practice, and advocacy that prioritizes
improving health outcomes and achieving health equity for all people worldwide who are affected
by neurosurgical conditions or need neurosurgical care” (Park et al., 2016). The literature identifies
five global neurosurgery domains: practice, research, health systems strengthening, advocacy, and
education (Shlobin, Sharma et al., 2022).
There are different ways in which individuals, scientific organizations, other civil society
groups, and academia engage in global neurosurgery to address the global challenges faced in
many low- and middle-income countries. Key strategies include surgical camps, educational
programs,

training

programs,

health

system

strengthening

projects,

health

policy

changes/development, and advocacy (Haglund & Fuller, 2019). However, current Neurosurgery
residency training programs or Pediatric Neurosurgery fellowships do not comprise curricula that
prepare neurosurgeons to be competent in assuming a role in public health advocacy. It is essential
to consider the challenges and benefits of international neurosurgical training programs to
effectively promote the development of neurosurgical care and prevention strategies for NTDs in
low- and middle-income countries (Gandy et al., 2020).
The research and advocacy domains of Global Neurosurgery strive to understand local
neurosurgical epidemiology to drive contextually adapted models of neurosurgical practice, to
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study the social determinants of neurosurgical conditions in all populations, and the diverse disease
trends that occur across different socioeconomic groups locally and abroad (Barthélemy et al.,
2018). These domains also promote using qualitative and quantitative methods to identify the
socio-economic effects of disparities in access to neurosurgical care and to study the impact of
innovative, enduring solutions for neurosurgical inequity. Finally, they promote partnering with
non-neurosurgical researchers to produce interdisciplinary team science approaches and
participate in local, national, regional, and global initiatives to influence policies that regulate the
healthcare ecosystems of patients with neurosurgical conditions (Barthélemy et al., 2018).
Organized neurosurgery plays an essential role in neurosurgical advocacy. The liaison
committee between the WHO and the World Federation of Neurosurgical Societies (WFNS) works
to advance access to quality care for neurosurgical patients globally (Rosseau et al., 2018).
National and regional neurosurgical societies play an important role in advancing the global
neurosurgical agenda, including ways to influence public policies impacting the incidence and
effects of conditions that affect the human nervous system. In low- and middle-income countries,
contributions include advocating for compiling information regarding the neurosurgical disease
burden and accurate reporting of human health resources, and may also include evaluation of
resource-stratified interventions, policies, and equipment (Rosseau et al., 2018).
Neurosurgical efforts have explored different advocacy mechanisms, including economic
contributions to campaigns of lawmakers who support policy issues important to neurosurgery
(Agarwal et al., 2020). However, a survey of nearly half of pediatric neurosurgeons affiliated with
the American Society for Pediatric Neurosurgery (ASPN) revealed that members prioritized public
health and clinical issues that affected children over economic matters (LoPresti et al., 2019). The
survey yielded data regarding pediatric neurosurgeons’ attitudes that may assist with designing a
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successful advocacy program. Most respondents favored drafting position statements on critical
issues and partnerships with larger organizations to pursue an advocacy agenda (LoPresti et al.,
2019).
Few publications address the role of neurosurgeons as KOL and how they might act as
knowledge brokers to facilitate the adoption, implementation, and scaling-up of MFF as an
evidence-based policy to prevent NTDs. The ISPN constituted a Spina Bifida Global Taskforce
with the multi-national and multidisciplinary collaboration of individuals and organizations
interested in the primary prevention of major folic acid-sensitive NTDs. This organization stated
that pediatric neurosurgeons are essential science-based advocates for MFF policies, with the
potential to spearhead the protection of thousands of children in all countries (Caceres et al., 2021).
One seminal paper to this dissertation highlights the central role that neurosurgeons and
organized neurosurgery can play in advocating for a more comprehensive, global-scale folate
fortification to avoid the most common and severe birth congenital malformation that affects the
human nervous system due to their accumulated experience dealing with these conditions and their
high standing in society (Estevez-Ordonez et al., 2018). These authors propose that assertive,
proactive, informed advocacy for folate fortification should be a central and integral part of the
neurosurgical approach to NTDs. Furthermore, they recommend eight steps to materialize this
advocacy, as listed below.
1) Neurosurgeons and neurosurgical professional organizations must serve as powerful
advocates for MFF with folic acid
2) Forming partnerships with local and international colleagues to advance basic and clinical
research
3) Supporting improved registry and surveillance efforts on a local and global scale
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4) Advocating for increased prenatal screening of NTDs
5) Supporting the establishment of comprehensive countrywide centers of excellence to
integrally approach NTDs through a combination of advocacy, international collaboration,
and funding
6) Working to establish and expand partnerships between their institutions and existing NTD
centers in developing countries
7) NTD advocacy organizations and organized neurosurgical groups must expand the
availability of multidisciplinary conferences on NTD prevention and multidisciplinary
management across the world
8) International initiatives can provide country-level information on NTD prevalence and
local prevention and can serve as partners to effect significant change

Inferences for the current study
NTDs are devastating congenital anomalies that can diminish the affected individuals'
survival, health, and quality of life and impact families, society, and public health. MFF with folic
acid, the most effective public health intervention to prevent NTDs, has been available for more
than three decades, but still, more than 100 countries fail to fortify food with folic acid despite
being a robust evidence-based policy. This situation generates inequities in the burden of disease
on vulnerable populations, which is a current problem demonstrated by an increasing number of
recent publications addressing it. Separate disciplines, including medicine, nutrition, pediatrics,
public health, and epidemiology, have identified gaps and opportunities for implementing
strategies to adopt MFF as a public health intervention. However, there is a lack of crossdisciplinary research to move forward and include relevant stakeholders in the dialogue, aiming to
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scale up this evidence-based policy and reach thousands of communities that may benefit from the
intervention.
Important determinant factors acting as barriers and facilitators for implementing MFF as
an evidence-based policy are evident in the literature. Furthermore, the literature allows inferring
that policymakers of most Latin American states may lack knowledge of the benefits of scaling up
their policies for MFF to prevent folic acid-sensitive NTDs, improve the health status of their
communities, and promote the protection of a large number of children from these disabling but
preventable conditions. Not addressing this problem continues to pose negative consequences on
four levels: public health, society, family, and individuals. However, there is scarce information
in the literature on how to address this problem and to what extent knowledge translation
interventions can help achieve the goal of influencing policymakers’ decisions. Future exploration
of this problem might consider theories, models, and frameworks for materializing the role of
neurosurgeons and neurosurgical societies and the KT strategies that could leverage that advocacy
to ensure the reach, adoption, implementation, scaling-up, and sustainability of MFF as a robust
evidence-based policy to prevent NTDs.
Conceptual Framework
As discussed above, there is a robust body of evidence on MFF's efficacy, safety, and costeffectiveness as a successful public health intervention to prevent NTDs (CDC, 2020c; FFI, 2022;
Kancherla, 2018; Pachón et al., 2013). Therefore, this study focuses on the KT strategies to
influence policymakers in Latin America to update, optimize, enact and enforce MFF policies,
eventually leading to health outcomes impacting individuals, society, and public health.
This study’s primary constructs are mandatory food fortification, determinant factors
(barriers and facilitators) of innovation, knowledge translation strategies, knowledge brokers
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(KOL), knowledge users (policymakers), dissemination of evidence-based policies, stakeholder
engagement, advocacy, leadership, and lobbying. For this study, these primary constructs are
prioritized over secondary constructs such as health outcomes, prevalence, incidence, NTD
treatment, folic acid supplementation, and voluntary fortification.
Kingdon’s model describes how the convergence of problem, policy, and political streams
opens a window for policy entrepreneurs to promote new policies that enter the agenda of
policymakers (Kingdon, 2014). However, this model does not account for the critical factors
influencing the uptake of a specific evidence-based policy. Aarons’ model incorporates those
factors, but it does not consider the three streams of Kingdon’s model. Therefore, both models
could integrate streams and critical factors based on a published experience in mental health using
this approach (Aarons et al., 2011). Figure 2.4 illustrates the conceptual framework specifically
designed for this study using both models.

Figure 2. 4 A conceptual framework combining Kingdon’s and Aaron’s models for alignment of
multiple streams and contextual factors to disseminate MFAF as an EBP to prevent folic acidsensitive NTDs

Note. Ghotme - Own work, Based on Purtle, Dodson & Brownson (2018)
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The Knowledge to Action framework addresses the process of translating knowledge to
action as an iterative, dynamic, and complex process. It concerns the creation (knowledge funnel)
and application (action cycle) of knowledge (Graham et al., 2006; Straus et al., 2011). Although
the framework constitutes a cycle, users may need to utilize the phases out of sequence, depending
on the project. In this case, the development of a knowledge tool is followed by the assessment of
determinant factors for knowledge use and the selection, tailoring, and implementation of a KT
intervention (Figure 2.5).
Figure 2. 5 Specific steps of the Knowledge to Action Framework used in this study

Note. Adapted from the Knowledge to Action Framework (Graham, 2006), retrieved from
https://www.ncbi.nlm.nih.gov/pubmed/16557505 (2020)
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Chapter 3: Methods
Overview of Methodology
This study answered the following overarching research question: how may we describe
the factors contributing to the development and implementation of a KT strategy aiming to
influence policymakers regarding MFF for preventing NTDs in Latin American countries?
This question gave rise to quantitative, qualitative, and mixed-methods research questions,
presented in Table 3.1.
Table 3. 1 Quantitative, qualitative, and mixed-methods research questions of the study
QUANTITATIVE

QUALITATIVE

MIXED-METHODS

RESEARCH

RESEARCH QUESTIONS

RESEARCH QUESTION

QUESTION
What are the

How do the KOL describe their

In what ways do the

determinant factors

attitudes toward implementing and

interview data reporting the

influencing the use

disseminating the NeuroAdvocacy

views of KOL about using

of the

Toolkit to translate knowledge to

the NeuroAdvocacy Toolkit

NeuroAdvocacy

policymakers in their countries?

help to explain the

Toolkit as an

What are the perceptions of

quantitative results about

innovation to

KOL about appropriate dissemination

the determinant factors for

promote robust MFF

mechanisms of the NeuroAdvocacy

implementing the

policies in Latin

Toolkit?

innovation?

America?

Note: MFF: mandatory food fortification; KOL: key opinion leaders
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The study's overall purpose is to describe the factors contributing to developing and
implementing a KT strategy aiming to influence policymakers in Latin American countries
regarding MFF to prevent NTDs. The KT strategy relies on neurosurgeons' and professional
organizations’ advocacy and leadership in brokering knowledge to policymakers and other
stakeholders. The ultimate goal was to design a dissemination strategy tailored to the needs for
regulatory change and contextual aspects of Latin American countries.
This study used a mixed-method explanatory sequential design to describe the factors
contributing to developing and implementing the KT strategy with the NeuroAdvocacy Toolkit as
the central component. The selected design utilized the follow-up explanations variant, which
prioritizes the initial quantitative phase, and uses the subsequent qualitative phase to explain the
quantitative results (Creswell & Plano Clark, 2017). The rationale for collecting quantitative and
qualitative data was to obtain a deeper understanding of the critical factors for developing and
implementing the innovation (the NeuroAdvocacy Toolkit), along with the KOL’s engagement,
motivation, and intention to act in disseminating it. Studying those aspects together cannot be
achieved only with one data source.
In dissemination and implementation research, mixed-method studies are the preferred
design to identify the determinant factors acting as barriers or facilitators to implementing
innovations. Besides, they help develop strategies and conceptual models of implementation,
monitoring the implementation process, and increase the probability of the long-term sustainability
of successful innovations (Palinkas & Cooper, 2018).
The selection of this design was founded on a pragmatic worldview combining quantitative
and qualitative approaches. It draws elements of the multiple streams model for policy
dissemination (Kingdon, 2003) and the Knowledge to Action Framework (Graham et al., 2006).
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The study follows Maxwell’s interactive model for research design to align the theoretical
framework with the goals, research question, and methodology (Maxwell, 2012). It generated
trustworthy, credible, confirmable, and transferable data on effectively achieving knowledge
translation mechanisms to decision-makers for adopting evidence-based policies to protect
thousands of children from NTDs, as disabling but preventable conditions.
The central hypothesis of this study implies that diverse determinant factors can act as
barriers and facilitators for developing and implementing the NeuroAdvocacy toolkit. Several
factors described in the literature can be present in different degrees, or sometimes absent,
according to specific contexts in which the innovation intends to promote change. Testing the
hypothesis involved utilizing a validated instrument to identify influencing factors for
implementing innovations. To explain the results generated by the quantitative assessment of
determinant factors, phenomena such as motivation, engagement, and intention to broker
knowledge to policymakers in Latin American countries are crucial for a deeper understanding of
the role of KOL in implementing the NeuroAdvocacy Toolkit. Furthermore, the KOL perspectives
and their attitudes towards advocacy, leadership, and lobbying constitute additional phenomena
whose exploration provides insightful notions for future dissemination of the innovation. The
combination of the data obtained from this study’s quantitative and qualitative inquiries addressed
the factors influencing the implementation of the NeuroAdvocacy Toolkit and the development of
a tailored dissemination strategy for approaching policymakers and calling them to action.
Research Procedures

The study comprised three sequential phases, illustrated in Figure 3.1. The three-phases
layout proposes a logical sequence of the study's main activities and outputs.
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Figure 3. 1 Phases, activities, and outputs of the study

Note: Ghotme, own work, created with SmartArt. MIDI: Measurement Instrument for
Determinants of Innovations

Phase 1
In the first phase of the study, a document analysis provided factual data regarding the
status and content of current legislation for MFF in the 20 Latin American countries, along with
the local prevalence of NTD and nutritional situation. The data gathered were codified to explore
common ground (or lack thereof) in terms of policies, followed by a needs assessment for
regulatory change contextualized to each country.
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Sampling. Phase 1 included documents from the 20 Latin American countries, including
publicly available official documents about MFF policies, epidemiological data regarding the
prevalence of NTDs, and national nutritional situation surveys to evaluate the MFF’s status and
perform the needs assessment for regulatory change.
Data collection. Document analysis provided data regarding the status and content of
current legislation for MFF in Latin American countries concerning the nutritional practices and
the prevalence of NTDs. Data were collected from three sources:
1) Public legislation records, repositories of the Food Fortification Initiative, and the
Global Fortification Data Exchange were the primary sources of specific regulations
regarding MFF.
2) Publicly available epidemiological data from official sites and peer-reviewed
publications
3) Periodical results regarding the national nutritional situation for each country, when
available
A data collection matrix/instrument in Excel helped to organize data and facilitate
comparisons among regulations, epidemiological data, and nutritional situations.
Data analysis. The data gathered were codified to generate a needs assessment for
regulatory change contextualized to each country. The needs assessment facilitated discerning
which Latin American countries require modifications of current regulations to enhance MFF's
reach, adoption, implementation, scaling-up, and sustainability.
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According to the needs assessment, countries were classified into mutually exclusive
categories reflecting the priority for regulatory change (See Chapter 4 for a detailed description of
the categories and the criteria to allocate countries to each of them).
Output. This phase's output was the NeuroAdvocacy Toolkit's design and development as
the innovative KT strategy. To include the voices of the innovation's target audience in designing
the Toolkit, semi-structured interviews with pre-set topics were conducted with three selected
policymakers to explore goals, expectations, and preferred mechanisms for knowledge translation.
The interview protocol, whose topics were refined after the completion of the needs assessment,
is presented in Appendix A.
Phase 2
For this quantitative phase, a cross-sectional survey was utilized to gather data from KOL
at the national pediatric neurosurgery societies in Latin America regarding the determinants for
implementing the NeuroAdvocacy Toolkit. The survey instrument was adapted from a published
and validated questionnaire that evaluates the determinants for implementing innovations
(Dugstad et al., 2014; Fleuren et al., 2014). The instrument is described in detail in the data
collection subsection.
Sampling. This stage approached all Latin American pediatric neurosurgical societies,
pediatric chapters of national neurosurgical associations, or organized groups of pediatric
neurosurgeons through ASOLANPED, with a greater emphasis on those countries identified as
having an urgent or high need for action, according to the needs assessment in Phase 1. The
recruitment rate was 100% of the 20 pertaining societies. Purposive sampling aided in identifying
one to three KOL per participating country among the executive boards of the neurosurgical

54

societies. These participants were men and women, ages 35 to 75 years old, with postgraduate
degrees, whom their peers identified as local KOL due to their experience, advocacy, leadership,
and lobbying abilities. In total, the number of respondents for the survey was 30. As a preliminary
step to data collection, the innovation, i.e., the NeuroAdvocacy Toolkit, was introduced and
explained to the KOL at in-person and online scientific meetings held in Latin American countries.
Data collection. The second phase comprised gathering quantitative survey data via the
online application of the Measurement Instrument for Determinants of Innovations (MIDI)
questionnaire through SurveyMonkey®, an open-source software tool.
The MIDI maps the determinants that influence the use of innovation in practice (Fleuren
et al., 2014). It originally started from 50 potentially relevant innovation determinants and initially
focused on healthcare organizations. Further development and refinement of the instrument used
a systematic review, a Delphi panel, and empirical studies, leading to 29 potential determinant
factors classified into four categories according to their association with the innovation, the user,
the organization, and the socio-political context (Fleuren et al., 2014; Fleuren et al., 2004). See
Appendix B for a detailed description of the 29 determinant factors organized into four categories.
The MIDI, validated in languages such as Dutch, English, and Norwegian (Dugstad et al.,
2014; Fleuren et al., 2013), offers a comprehensive framework and allows the quantification of the
presence or absence of a determinant. The MIDI questionnaire was adapted and operationalized to
fit the purposes of this study. Adaptations to the instrument were made in consultation with the
author of the MIDI. Appendix B contains the operationalization and response scale for each
determinant factor adapted for this study.
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The questionnaire was translated into Spanish by a native speaker. The translated version
of the questionnaire was assessed by a separate independent translator (who did not know the
original text) and translated back into the original language. For reconciliation, the original text
was compared with the back translation to look for potential issues where the meaning was
confusing or slightly off, leading to a refined version of the questionnaire in Spanish. Afterward,
it was validated and adjusted through pilot surveys with five experts in the field. The validated
questionnaire was then pilot-tested on three respondents purposefully selected from Argentina,
Colombia, and Costa Rica, looking for comprehensibility. Minor adjustments were made for
clarity without affecting the meaning of statements or answers; therefore, the pilot survey data
were included in the final quantitative analysis.
Data analysis. Data were processed in SPSS version 27. Descriptive analysis of the survey
responses included frequency of responses for each factor and proportion of positive responses.
For this study, ordinal variables (Likert scales) were considered positive when the participants
predominantly selected the options “agree,” “completely agree,” or their equivalent. Only the
“yes” option was considered a positive response for nominal variables. Although the MIDI
questionnaire does not have a standard cut-off to establish how determinant a factor can be for a
specific innovation, an 80/20 rule was applied to assess the answers based on previous experiences
in the application and interpretation of the responses to the questionnaire (Fleuren, personal
communication, 2020). If one specific factor had a percentage of agreement of less than 20% of
the time, it was considered a barrier; explicit adjustment strategies must be placed to overcome
that anticipated barrier to implementation. If another factor had a percentage of agreement of more
than 80% of the time, it was considered a facilitator; no specific actions are needed to adjust the
implementation strategy for that factor, or its presence could leverage implementation and
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dissemination plans. An individualized analysis was performed for factors with an agreement
percentage between 20 and 80% and then considered potential barriers or facilitators. See Chapter
4 for a detailed explanation of the factors’ assessment using the rule mentioned earlier.
Subsequently, the frequency of responses for each factor was organized in a joint display
table according to the respondents’ country in the categories elicited in Phase 1 related to the need
for regulatory change. The table facilitated examining, on a granular level, potential differences
between participants’ responses, depending on the priorities for regulatory change in their
countries. The analysis was conducted independently for each of the 29 factors in a descriptive
way and was not inferential or hypothesis-driven.
Output. This phase resulted in the refinement of the NeuroAdvocacy Toolkit in response
to the identified barriers and facilitators to the innovation by the KOL in a way that retains the core
components but contains customizable components, adaptable to local contexts.
Phase 3
A multiple case study design was utilized for collecting and analyzing the data in this
qualitative phase through interviews with the KOL. The instrumental multiple cases explored
KOL’s engagement, motivation, intention to act, and ideal delivery mechanisms of the
NeuroAdvocacy Toolkit.
Sampling. For Phase 3, a new purposive sampling based on Phase 2 allowed selecting a
representative group of KOLs for personal interviews, including at least one KOL per participating
country. Participants were also men and women, ages 35 to 75 years old, with postgraduate
degrees. Twenty-four interviews were conducted to reflect diverse perspectives on the phenomena
evaluated.
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Interview protocol development. The content of the interview protocol was grounded in
the quantitative results of the study's second phase. The interview protocol, including the pre-set
topics, is presented in Appendix C. The interview protocol was pilot-tested on one participant,
purposefully selected from those who had completed the survey in Phase 2. Minor adjustments
were made for clarity without affecting the meaning of pre-set topics or questions; therefore, the
pilot interview data were included in the final qualitative analysis.
Data collection. The interview questions reflect pre-set topics focused on the central
phenomena related to their perspectives on the factors influencing the implementation of the
NeuroAdvocacy Toolkit. These phenomena included but were not limited to engagement,
motivation, intention to act, and anticipated delivery mechanisms of the NeuroAdvocacy Toolkit.
All interviews, which lasted approximately 20 to 30 minutes, were conducted online, in Spanish,
through the Zoom® platform, except for an interviewee from one country where the platform use
was unavailable due to national regulations. In this case, the interview was conducted through a
WhatsApp® video call, and audio was recorded using a conventional recorder. All data were stored
in a secure storage location.
Data analysis. The recorded interviews were transcribed verbatim through the Microsoft
Office 360® transcription software. Data were analyzed and coded for thematic analysis of the
participants’ perspectives. The steps in the qualitative analysis based on Creswell & Plano Clark
(2017) included:
1) Preliminary exploration of the data by reading through the transcripts
2) Coding the data by segmenting and labeling the text
3) Using codes to develop themes by aggregating similar codes together
4) Connecting and interrelating themes
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5) Constructing a case narrative composed of descriptions and themes
6) Cross-case thematic analysis
The analysis was performed at two levels: within each case and across the cases (Creswell
& Plano Clark, 2017). A matrix structured in terms of the themes, subthemes, codes, and
representative verbatim participant’s quotes was used for displaying and further developing the
results in a way that reflected the qualitative data, including the verbatim quotes that addressed or
supported those categories (Maxwell, 2012).
Memoing and bracketing procedures were used to mitigate the potentially deleterious
effects of the researcher’s preconceptions. Trustworthiness was secured by triangulating different
sources of information, member checking, rich and thick descriptions of the cases, and reviewing
and resolving disconfirming evidence.
Finally, quantitative and qualitative data were synthesized and integrated. A joint display
table was developed to illustrate how the qualitative results (expressed in themes and direct quotes)
enhance the quantitative results in terms of the most relevant determinant factors. The value added
by the qualitative explanations was interpreted to provide a deeper understanding of the MIDI
questionnaire findings and additional insights and nuances.
Output. This phase’s output was a set of recommendations for the NeuroAdvocacy
Toolkit’s dissemination strategy, with fidelity to the core generalizable components and flexible
elements tailored to participating countries.
Limitations of the Study
Some of the limitations of the proposed project included potential threats to internal and
external validity. The first threat to internal validity is the lack of a comparison group; therefore,
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other events occurring within the study's timeframe may have generated the observed results
(Portney, 2020). In this case, using a single group was justified because the study did not have an
experimental manipulation. Instead, participants were approached in their natural setting. Finally,
the results of this study are generalizable only to Latin American countries due to their unique
social, cultural, and political reality.
There were also threats to trustworthiness, such as the risk of researcher bias for the
investigator being part of the strategy as a researcher and, at the same time, an advocate
participating in promoting policy implementation and dissemination. Therefore, it is essential not
to consider the researcher’s influence as a problem but to understand it and use it productively
(Maxwell, 2012). Bracketing procedures helped in mitigating this threat. Besides, there was a
potential risk for KOL’s reactivity affecting their responses due to their awareness of being part of
a study. However, reactivity can facilitate a deeper understanding of the phenomena studied and
more relevant and actionable findings. Using multiple methods for data collection served to control
threats to trustworthiness through triangulation, complementarity, and expansion procedures.
Since the surveys and interviews were conducted in Spanish and the results were processed,
analyzed, and reported in English, there was a possibility of confusion, ambiguities, or errors
arising from the nuances of language. Back translation and reconciliation procedures were
performed to ensure quality, accuracy, and equivalence of meaning between the participants'
answers and target texts. See the data collection subsections in this chapter for more details
regarding the translation, back translation, and reconciliation procedures.
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Human Participants and Ethics Precautions
The three stages of this study involved human participants who answered surveys and
interviews as professional experts. Although they did not constitute a vulnerable population, and
participation in the study involved no greater than minimal risk (under 45 CFR 46 / 21 CFR 56
regulations), respect for human subjects was granted throughout the study. Strict privacy and
confidentiality measures were in place to protect anyone who might be identifiable. Therefore, the
project was submitted through the GW Integrated Research Information Software (iRIS) and
approved by The Office of Human Research (OHR) of the George Washington University for
Institutional Review Boards review and monitoring (IRB# NCR203004, 03/22/2021).
Entering and remaining in the study was entirely voluntary to ensure participants’
autonomy, and refusal to participate did, by no means, affect the participants' status regarding their
relationship with ASOLANPED, their national neurosurgical organization, or their activities in
clinical practice.
From a justice standpoint, successful strategies to prevent NTDs decrease inequities,
improve the health status of their communities, and promote the protection of vulnerable children
from these disabling but preventable conditions.
Risks and benefits

Participants may have benefited from receiving updated information on NTDs and effective ways
to prevent them, as well as training in knowledge translation strategies that might, in turn, have
led to boosting their advocacy and leadership in promoting health and preventing conditions
related to the field. There was no material compensation for participating in this study, but the
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research budget covered expenses caused by attending the study activities. This study involved no
physical harm to participants; however, the surveys and interviews required dedicated time
(approximately 10 minutes for the online survey and 20 minutes for a remote interview) and had
the potential to elicit feelings of discomfort. Additionally, some participants might have hesitated
to expose their opinions due to fear of stigma or discrimination based on the specific situation of
their countries in terms of legislation to prevent NTDs or sociopolitical context.
Privacy and confidentiality

Privacy and confidentiality were ensured continuously during the recruitment and further
phases of the study, and data protection complied with the United States and local Latin American
regulations. The surveys were anonymized to protect participants’ privacy. For the interviews, the
names were replaced with a consecutive alphanumeric code on all study materials, and all
identifiable information was removed from the study formats. All study information was stored
securely in a locked cabinet and a password-protected file in a computer that was only accessible
to authorized research personnel. Once the study finished, records containing personal information
were deleted or shredded. Any information about individuals’ research involvement will not be
disclosed without written permission unless required by law. The study results published in
scientific meetings or journals might contain identifying information about the participating
countries but no identifiable data pertaining to individuals.
Participants were instructed not to discuss their answers or results with other participants.
However, non-identifiable participants’ answers obtained during the study's second phase were
disclosed in the qualitative phase for explanatory purposes during the interviews. Only the audio
part of the interviews was sent to the transcription service. Recordings will not be used in
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presentations or for any reason other than data analysis. When reporting the results, any direct
quotes were attributed to pseudonyms.
Informed consent and potential challenges
A separate informed consent form per phase was available through online software tools.
An introductory page contained all the information and included the option for clicking agreement
and electronic signature. Participants could also accept or decline being contacted for further
follow-up interviews or verification procedures. Records of the agreement were kept electronically
and were stored securely in a password-protected file on a computer that is only accessible to
authorized research personnel.
Potential challenges were considered during the informed consent process, including a
limited understanding of the research’s implications. Participants received understandable
language information and visual aids when needed to mitigate this challenge. Knowledge
verification was encouraged before signing the consent form. For any questions or concerns raised
by participants regarding the study, the student researcher was available synchronously (by chat)
at predetermined timeframes and asynchronously (by e-mail).
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Chapter 4: Results
This study used a mixed-method explanatory sequential design to describe the factors
contributing to developing and implementing a KT strategy to influence policymakers regarding
MFF to prevent NTDs in Latin American countries. The main results of the three phases, including
the toolkit development, are presented sequentially, followed by an integration of the quantitative
and qualitative data.
Phase 1: Status of MFF Legislation in Latin America and Need for Regulatory Change
A thorough document analysis led to identifying the regulatory status of MFF for the 20
Latin American countries and categorizing them according to the needs assessment for regulatory
change. This categorization pondered five factors: prevalence of NTDs, coverage of current
fortification regulations, the fortification standard in those regulations, the daily intake of nonfortified cereals, and the percentage of industrialization of the main cereal grains. Each factor was
pondered in a range from zero to three points to determine the level of priority by which a country
requires to update and optimize regulations for mandatory fortification (Table 4.1). The lower the
score, the higher the need for regulatory change.
The scores for each domain were estimated in comparable intervals. For instance, for the
NTD prevalence domain, the maximum score was given to the lowest prevalence achieved with
MFF policies (five cases or less per 10,000 live births) (CDC, 2020c, 2020a), and the subsequent
scores were allocated in groups of five.
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Table 4. 1 Priority for regulation change ponderation scale
ASPECT
NTD PREVALENCE (per 10,000 live births)
Prevalence > or = 20
Prevalence between 11 and 19
Prevalence between 6 and 10
Prevalence < or = 5
MANDATORY FORTIFICATION, INCLUDING FOLIC ACID
No mandatory fortification in place including folic acid
Mandatory fortification of 1 staple food

POINTS
0
1
2
3
0
1

Mandatory fortification of 2 staple foods
2
Mandatory fortification of 3 staple foods
3
FOLIC ACID CONCENTRATION IN FORTIFICATION STANDARD
No folic acid in the fortification standard
0
Folic acid below the recommended standard (<5 mg/kg)
1
Folic acid standard between 0.5 and 1 mg/kg
2
Folic acid standard between 1.1 and 2 mg/kg
3
CEREAL GRAIN DAILY INTAKE (WHEAT, CORN, RICE) IN GRAMS/PER
CAPITA/PER DAY
Daily intake of non-fortified food > or = 200
0
Daily intake of non-fortified food between 101 to 199
1
Daily intake of non-fortified food between 51 to 100
2
Daily intake of non-fortified food < or = 50 or fortification in place
3
INDUSTRIALIZATION PERCENTAGE (PER TYPE OF CEREAL GRAIN)
Percentage of reported industrialized food processing 0-30%
0
Percentage of reported industrialized food processing 31-60%
1
Percentage of reported industrialized food processing 61-90%
2
Percentage of reported industrialized food processing 91-100%
3

This ponderation led to establishing four levels of priority in acting to change regulations:
Priority 1 (0 to 5 points): Urgent need for regulatory change
Priority 2 (5.1 to 10 points): High need for regulatory change
Priority 3 (10.1 to 14.9 points): Medium need for regulatory change
Priority 4 (15 points): No need for regulatory change
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Table 4.2 displays the needs assessment results for every country with the granular detail
of the five domains leading to the individual scores. Dominican Republic, Haiti, Peru, and
Venezuela require urgent regulatory changes to effectively fortify staple food with folic acid
(Priority 1). Fourteen countries have a high need for regulatory change; this group includes
Argentina, Bolivia, Brazil, Colombia, Chile, Cuba, Ecuador, El Salvador, Guatemala, Honduras,
Mexico, Nicaragua, Paraguay, and Uruguay (Priority 2), whereas Panama was categorized in
Priority 3 with a medium need for regulatory change. Only one country, Costa Rica, was classified
in Priority 4 with no need for regulatory change since it has extensive coverage of fortification of
staple foods with folic acid with the recommended standards and the region’s minimum prevalence
of NTDs achievable with this policy.
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Table 4. 2 Priorities for regulation change in Latin American countries according to the needs assessment
FOLIC ACID CONCENTRATION IN
FORTIFICATION STANDARD
Wheat Maize
Rice Average
flour
flour
3
0
0
1.0

NTDs
PREVALENCE

MANDATORY
FORTIFICATION

Argentina

1

1

Bolivia

1

1

3

0

0

Brazil

0

2

3

3

Chile

2

1

3

0

Colombia

2

1

3

Costa Rica

3

3

Cuba
Dominican
Republic
Ecuador

2

COUNTRIES

CEREAL GRAIN DAILY INTAKE
Wheat
flour
3

Maize
flour
3

1.0

3

0

2.0

0

1.0

0

0

3

3

1

3

1

1

2

El Salvador
Guatemala

INDUSTRIALIZATION
PERCENTAGE PER CEREAL GRAIN
Wheat Maize
Rice Average
flour
flour
3
3
3
3.0

Rice

Average

3

3.0

1

1

1.7

2

0

0

3

3

1

2.3

3

3

3

2

3

2.7

3

0

1.0

3

2

1

2.0

3

3

3.0

3

3

3

3.0

0

0

1.0

3

2

0

3

0

0

1.0

3

3

1

3

0

0

1.0

3

2

2

3

2

0

1.7

0

2

1

3

0

1.3

Haiti

1

0

0

0

0

Honduras

1

1

3

0

Mexico

1

2

3

3

Nicaragua

2

2

3

Panama

2

2

Paraguay

2

Peru

TOTAL
POINTS

PRIORITY IN
REGULATORY
CHANGE

9.0

2- High need

0.7

5.3

2- High need

3

3.0

9.3

2- High need

0

1.0

7.7

2- High need

0

2

1.7

7.7

2- High need

3

3

3

3.0

15.0

4- No need

1.7

3

0

0

1.0

6.7

0

2.0

0

0

0

0.0

5.0

2- High need
1- Urgent
need

1

1

1.7

3

0

0

1.0

6.7

2- High need

3

3

3

3.0

3

0

0

1.0

9.7

2- High need

1

3

3

2.3

0

0

0

0.0

5.7

0.0

2

2

1

1.7

3

0

0

1.0

3.7

2- High need
1- Urgent
need

0

1.0

3

0

2

1.7

3

0

0

1.0

5.7

2- High need

0

2.0

3

3

3

3.0

3

1

0

1.3

9.3

2- High need

0

2

1.7

3

1

3

2.3

3

0

0

1.0

9.0

3

0

2

1.7

3

2

3

2.7

3

0

3

2.0

10.3

2- High need
3- Medium
need

1

3

0

0

1.0

3

1

3

2.3

3

0

3

2.0

8.3

0

1

3

0

0

1.0

3

2

0

1.7

0

0

0

0.0

3.7

Uruguay

1

1

3

0

0

1.0

3

2

3

2.7

3

0

1

1.3

7.0

Venezuela

1

0

0

0

0

0.0

1

1

2

1.3

3

0

0

1.0

3.3

2- High need
1- Urgent
need
2- High need
1- Urgent
need
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Toolkit Development
The scientific literature, data on the current status of MFF policies in Latin America, the
needs assessment, and voices from the target audience informed the NeuroAdvocacy Toolkit
development and its core components. This last interaction with the target audience as future
knowledge users occurred through semi-structured interviews with three policymakers
purposefully selected in Colombia, Chile, and Costa Rica. The interviews conducted in this
phase had an exploratory purpose. Participants reviewed the toolkit drafts, suggested
adjustments, and discussed preferred knowledge transfer and utilization mechanisms.
Drawing from the interview data, Table 4.3 summarizes the conventional sources of
information that policymakers and their teams seek when guiding their decisions based on
scientific evidence, the main challenges in gathering information or using the knowledge
obtained, and the mechanisms they foresee could help to overcome those challenges.
The interviewees also discussed their preferred mechanisms for receiving and using
knowledge to inform their decisions about adopting or implementing public policies. They
highlighted the need to access scientific evidence, the essential role of experts in a particular
field in translating that evidence, and how a toolkit like the one proposed to them in this stage
could accelerate knowledge comprehensibility and utilization.
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Table 4. 3 Conventional sources of information, challenges, and strategies for knowledge
utilization according to selected policymakers interviewed in Phase 1
CONVENTIONAL SOURCES
OF INFORMATION

USUAL CHALLENGES

POTENTIAL STRATEGIES TO
OVERCOME CHALLENGES

Health bulletins from
supranational
organizations

Reluctance to adapt
to local contexts,
other priorities

Access to knowledge
translation
mechanisms/generate
awareness

Government agencies

Bureaucracy

Generate awareness,
enhance national registries

Expert advisor committee
Scientific journals,
databases

Different
priorities/agenda
Language barriers,
excessively technical
information, timeconsumption

Advocacy/lobbying/
awareness
Access to knowledge
translation mechanisms

The toolkit, designed in a visually appealing format, includes a slide deck to present a
five-minute “elevator pitch” before policymakers, containing critical facts, data, and an
interactive map illustrating each country’s legislation status and need for regulatory change. It
ends with a call to action to update, scale up, implement, ensure sustainability, and optimize
surveillance of fortification policies with folic acid. The toolkit’s second piece is a printable
infographic sheath summarizing the pitch deck's information, highlighting a call to action. The
third element is an evidence brief that organizes some of the best scientific data in a visual and
interactive format for a quick consult, with hyperlinks that give free access to the full-text Pdf
articles. The last toolkit component summarizes successful legislations from Costa Rica and the
United States as reliable models of complete and adequate coverage of the fortification of cereal
grains and the lowest prevalence of NTDs achievable with these policies. Current toolkit
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elements are presented in Spanish, the native language of the innovation’s intended users and
target audience; nevertheless, it is customizable for English, Portuguese, and French versions.
The four pieces constituting the Toolkit can be consulted and downloaded free of charge
at www.neuroadvocacy.info, a web page specifically created for this purpose. After obtaining
official endorsement by ASOLANPED, the toolkit was introduced to an estimated 270 Latin
American pediatric neurosurgeons, residents, and fellows at in-person scientific meetings held in
Mexico, Ecuador, Peru, and Brazil. Additionally, it was introduced through several virtual
meetings to another 325 pediatric neurosurgeons practicing in 20 Latin American countries.

Phase 2: Quantitative Strand
After being introduced to the NeuroAdvocacy Toolkit, 30 KOL (22 men and eight women,
aged 35 to 75) responded to the survey using the MIDI questionnaire. The recruitment rate for this
phase was 94%, and the response rate was 100%. Participants from the 20 Latin American
countries were included, with a greater representation of those with a larger community of pediatric
neurosurgeons, such as Brazil or Mexico (Figure 4.1).
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Figure 4. 1 Distribution of the survey respondents’ countries of practice

Participants’ responses were tabulated, and the percentage of positive responses was
calculated for each factor independently. For this study, ordinal variables (Likert scales) were
considered positive when the participants predominantly selected the options “agree,” “completely
agree,” or their equivalent. Only the “yes” option was considered a positive response for nominal
variables. An 80/20 rule was applied to assess the answers. If one specific factor had a percentage
of agreement of less than 20% of the time, it was considered a barrier; explicit adjustment strategies
must be placed to overcome that anticipated barrier to implementation. If another factor had a
percentage of agreement of more than 80% of the time, it was considered a facilitator; no specific
actions are needed to adjust the implementation strategy for that factor, or its presence could
leverage implementation and dissemination plans. An individualized analysis was performed for
factors with an agreement percentage between 20 and 80%, which were considered either potential
barriers or facilitators. For factors 4 (complexity) and 26 (unsettled organization), the rule was
applied inversely since those factors are expected to behave as usual barriers to implementation,
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i.e., the lower the percentage of agreement, the lower the need to implement specific actions to
overcome these factors.
First category: determinants associated with the innovation.

Answers in this category were homogeneous. Responses consistently allowed classifying
all factors associated with the Toolkit as implementation facilitators (Table 4.3). Therefore, no
specific actions are required to adjust the implementation strategy for these seven factors, and the
Toolkit attributes could leverage implementation and dissemination plans.

Table 4. 4 Determinant factors in implementing the NeuroAdvocacy Toolkit associated with the
innovation

Determinants associated with the innovation
Determinant

Name

1

Procedural clarity

2

Correctness

3

Completeness

4

Complexity

5

Compatibility

Description
The extent to which
the innovation is
described in clear
steps/procedures
The degree to which
the innovation is
based on factually
correct knowledge
The degree to which
the activities
described in the
innovation are
complete
The degree to which
the implementation of
the innovation is
complex
The degree to which
the innovation is
compatible with the

Percentage
of
agreement

Type of
factor

93.3%

Facilitator

93.3%

Facilitator

96.7%

Facilitator

3.3%

Facilitator

100%

Facilitator
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values and working
method in place

6

Observability

Visibility of the
outcomes for the user

93.3%

Facilitator

The degree to which
the user believes the
7
100%
Facilitator
innovation is relevant
for policymakers
Note: For factor 4, the percentage of agreement was considered inversely since it is
Relevance for
client

expected to behave as a barrier to implementation (the lower the agreement percentage, the lower
the need to implement specific actions to overcome this factor)
Second category: determinants associated with the user
Responses in this category were also homogeneous. Participants’ answers consistently
allowed classifying all factors associated with the user as facilitators of implementation (Table
4.4). Therefore, no specific actions are required to adjust the implementation strategy for these 11
factors, and the intended users’ knowledge, attitudes, and beliefs could leverage implementation
and dissemination plans.
Table 4. 5 Determinant factors in implementing the NeuroAdvocacy Toolkit associated with the
user (key opinion leaders)

Determinants associated with the user
Name

Description

Percentage
of
agreement

8

Personal
benefits/drawbacks

The degree to which
using the innovation
has advantages or
disadvantages for the
users themselves

92%

Facilitator

9

Outcome
expectations

Perceived probability
and importance of

100%

Facilitator

Determinant

Type of
factor

74

10

Professional
obligation

11

Client satisfaction

12

Client cooperation

13

Social support

14

Descriptive norm

15

Subjective norm

16

Self-efficacy

achieving the client
objectives as intended
by the innovation
The degree to which
the innovation fits in
with the tasks for
which the user feels
responsible when
doing their work
The degree to which
the user expects
policymakers to be
satisfied with the
innovation
The degree to which
the user expects
policymakers to
cooperate with the
innovation
Support experienced
or expected by the
user from important
social referents
relating to the use of
the innovation (for
example, from
colleagues, other
professionals they
work with, heads of
department, or
management)
Colleagues' observed
behavior: the degree
to which colleagues
use the innovation
The influence of
important others on
the use of the
innovation
The degree to which
the user believes they
can implement the
activities involved in
the innovation

96.3%

Facilitator

100%

Facilitator

93.3%

Facilitator

90.0%

Facilitator

93.3%

Facilitator

83.3%

Facilitator

100%

Facilitator

75

17

Knowledge

18

Awareness of
content of
innovation

The degree to which
the user has the
knowledge needed to
use the innovation
The degree to which
the user has learned
about the content of
the innovation

90.0%

Facilitator

96.7%

Facilitator

Third category: determinants associated with the organization (national neurosurgical
societies and ASOLANPED)
Responses in this category were heterogeneous (Table 4.5). Participants’ answers led to
classifying factors 19 (the absence of formal ratification by management) and 25 (the lack of
designation of a coordinating individual or group) as barriers to implementing the innovation.
Since ASOLANPED has officially endorsed the initiative, specific action is needed to adjust the
implementation strategy for these two factors targeting the national neurosurgical associations.
The remaining eight factors are either facilitators or potential facilitators, requiring minimum
adjustments, if any, to take advantage of them to leverage implementation and dissemination plans.

Table 4. 6 Determinant factors in implementing the NeuroAdvocacy Toolkit associated with the
organization (national neurosurgical societies and ASOLANPED)

Determinants associated with the organization
Determinant

19

Name

Description

Formal ratification of
the innovation by
management, for
Formal ratification
example, by including
by management
the use of the
innovation in policy
documents

Percentage
of
agreement

Type of
factor

16.7%

Barrier

76

20

Replacement when
staff leave

21

Staff capacity

22

Financial
resources

23

Time available

24

Material resources
and facilities

25

Coordinator

26

Unsettled
organization

Continuity of policies
and initiatives despite
staff transitioning the
organization
Adequate staffing in
the department or in
the organization
where the innovation
is being used
Availability of
financial resources
needed to use the
innovation
Amount of time
available to use the
innovation
Presence of materials
and other resources or
facilities necessary
for the use of the
innovation as
intended (such as
equipment, materials,
or space)
The presence of one
or more persons
responsible for
coordinating the
implementation of the
innovation in the
organization
The degree to which
there are other
changes in progress
(organizational or
otherwise) that
represent obstacles to
the process of
implementing the
innovation, such as
re-organizations,
mergers, cuts, staffing
changes, or the
simultaneous
implementation of
different innovations

70%

Potential
facilitator

70%

Potential
facilitator

73.4%

Potential
facilitator

76.7%

Potential
facilitator

73.4%

Potential
facilitator

13.3%

Barrier

6.7%

Facilitator
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Information
accessible about
the use of
innovation

27

Accessibility of
information about the
use of the innovation

Potential
facilitator

70%

Feedback to the user
Performance
about progress with
Potential
63.3%
28
facilitator
feedback
the innovation
process
Note: For factor 26, the percentage of agreement was considered inversely since it is
expected to behave as a barrier to implementation (the lower the agreement percentage, the lower
the need to implement specific actions to overcome this factor)

Fourth category: determinant associated with the socio-political context
Most respondents considered that the innovation fits in with existing legislation and
regulations established by the competent authorities in Latin America (Table 4.6). Therefore, no
specific actions are required to adjust the implementation strategy for factor 29, which could
actually leverage implementation and dissemination plans.

Table 4. 7 Determinant factor in implementing the NeuroAdvocacy Toolkit associated with the
Latin American socio-political context

Determinant associated with the socio-political context
Determinant

29

Name

Description

Percentage
of
agreement

Legislation and
regulations

The degree to
which the
innovation fits
in with existing
legislation and
regulations
established by
the competent
authorities

83.3%

Type of
factor

Facilitator
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Determinant factors according to country categories
After analyzing data from all respondents respective to each factor, the frequency of
positive responses was organized in a joint display table according to the respondents’ country
location in the four priorities elicited in Phase 1: no need, medium need, high need, and urgent
need for regulatory change (Table 4.7). The table facilitated examining, on a granular level,
potential trends between participants’ responses, depending on the priorities for regulatory change
in their countries. The analysis was conducted independently for each of the 29 factors and was
not inferential or hypothesis-driven. This descriptive analysis applies only to the respondents
included in the study and their respective countries.
The factors associated with the innovation, user, and socio-political context were
consistently facilitators for all country categories. In contrast, factors associated with the
organization showed a more heterogeneous pattern, especially for factors 23 (time availability), 24
(availability of material resources and facilities), and 28 (performance feedback). This
heterogeneity in the response pattern was found in the countries of categories 2 (high need for
regulatory change) and 3 (medium need for regulatory change), although this last category
corresponds to only one participant.
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Table 4. 8 Determinant factors in implementing the NeuroAdvocacy Toolkit according to country categories for priority in regulatory change
DETERMINANT FACTORS
Frequency of
positive responses
according to
country category

Associated with the
innovation (NeuroAdvocacy
Toolkit)

1 2 3
Priority 1:
5 5 5
Urgent need (n=5)
Priority 2:
22 21 22
High need (n=23)
Priority 3:
1 1 1
Medium need (n=1)
Priority 4:
1 1 1
No need (n=1)

Associated
Associated with the organization
with socio(national neurosurgical organization and
political
ASOLANPED)
context

Associated with the user (key opinion
leaders)

4

5

6

7

8

9

10 11 12 13 14 15 16 17 18 19 20 21 22

23

24 25 26 27 28

29

0

5

5

5

4

5

5

5

1

5

5

5

5

2

1

4

4

4

1

23 22 23 22 23 23 23 22 22 22 18 23 20 22

3

15 15 17

17

16

4

0

18 18

21

0

1

1

1

1

1

1

1

1

1

1

1

1

1

1

0

1

1

1

0

0

0

0

1

0

1

0

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

0

0

1

1

1

5

5

4

5

4

5

5

5

Note: ordinal variables (Likert scales) were considered positive when the participants predominantly selected the options
“agree,” “completely agree,” or their equivalent. Only the “yes” option was considered a positive response for nominal variables.
For factors 4 and 26, the response was considered inversely since they usually behave as barriers to implementation (the lower the
the number of positive responses, the lower the need to implement specific actions to overcome this factor).
Color code:

Facilitator
Potential facilitator
Potential barrier
Barrier
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Phase 3: Qualitative Strand
Twenty-four KOL purposefully selected from the survey respondents (16 men and eight
women, aged 35 to 75) participated in online semi-structured interviews (recruitment rate 100%,
response rate 100%). Again, participants from the 20 Latin American countries were included,
with a greater representation of Brazil and Mexico for having a larger community of pediatric
neurosurgeons. The qualitative data yielded three themes, nine subthemes, and 34 codes
describing the attitudes toward using the Toolkit, the ideal delivery strategies to policymakers,
and how to face potential challenges during the implementation and dissemination process
effectively.
Theme 1: Attitudes toward using the toolkit
Participants in this phase richly described their attitudes toward using the NeuroAdvocacy
Toolkit as an innovative KT strategy to approach policymakers in their own countries. Four
subthemes (motivation, engagement, intention to act, and potential drawbacks) grouped 11 codes
representing these attitudes. Most participants expressed positive and proactive attitudes toward
brokering knowledge to policymakers, including empathy, inspiration, awareness, confidence,
gratification, commitment, emulation, and readiness (Figures 4.2, 4.3, and 4.4). These phenomena
are congruent with the determinants associated with the toolkit and the intended users reflected in
the MIDI questionnaire. Nonetheless, some participants also expressed a few potential drawbacks
regarding their future involvement in using the toolkit, including hesitation due to time constraints
or the need to prioritize clinical practice, inertia or apathy, and potential frustration from poor
policymakers' attention to the initiative (Figure 4.5). Although these potential drawbacks were not
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evident in the quantitative phase, they represent real-life scenarios when it comes to putting the
innovation into action.
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Figure 4. 2 Theme 1: Attitudes toward using the NeuroAdvocacy Toolkit. Subtheme 1: Motivation
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Figure 4. 3 Theme 1: Attitudes toward using the NeuroAdvocacy Toolkit. Subtheme 2: Engagement
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Figure 4. 4 Theme 1: Attitudes toward using the NeuroAdvocacy Toolkit. Subtheme 3: Intention to act
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Figure 4. 5 Theme 1: Attitudes toward using the NeuroAdvocacy Toolkit. Subtheme 4: Potential drawbacks

83

Theme 2: Strategies to deliver the NeuroAdvocacy Toolkit to policymakers
The interviewees, positioned as KOL, discussed the ideal mechanisms by which they
could deliver the toolkit more effectively. Three subthemes (ideal channels, initial approaches,
and follow-up strategies) grouped nine codes representing these mechanisms.
The figure of a gatekeeper (personal contacts, intermediaries, colleagues working on the
policymaker role) was preeminent, as well as the idea of using collective efforts of organized
neurosurgery and interdisciplinary teams to move the initiative forward and not as an individual
quest (Figure 4.6). For the initial approach, there was consensus among participants that
organizing an in-person meeting with policymakers or their delegates would be more impactful
than making the first interaction virtually. Although they recognize the value of online platforms,
especially in post-pandemic times, participants do not prefer virtual meetings, e-mails, or sharing
digital material without a previous in-person meeting for the initial knowledge translation
moment with policymakers. Most interviewees see virtual meetings as having a role in follow-up
sessions (Figure 4.7). Participants pointed out systematic, continuous, and persuasive follow-up
strategies to increase the probabilities of policymakers’ knowledge use and intention to act
(Figure 4.8).
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Figure 4. 6 Theme 2: Delivery strategies of the Toolkit to policymakers. Subtheme 5: Ideal channels
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Figure 4. 7 Theme 2: Delivery strategies of the Toolkit to policymakers. Subtheme 6: Initial approach
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Figure 4. 8 Theme 2: Delivery strategies of the Toolkit to policymakers. Subtheme 7: Follow-up strategies
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Theme 3: Bringing policymakers on board
Participants described the challenges that might be faced and the strategies to increase the
likelihood of convincing and encouraging policymakers to strengthen MFF to prevent NTDs.
Fourteen codes representing these aspects were grouped into two subthemes (challenges and
strategies).
The main challenges included politicians prioritizing their own agenda or seeking
political revenues or personal profit (Figure 4.9), excessive bureaucracy, policymaker’s lack of
knowledge or understanding of the problem’s dimension and the need to take action, distrust
among parties or stakeholders (Figure 4.10), indolence, cynicism, and negativity. Participants
particularly highlighted science skepticism as an emergent challenge in the post-pandemic era
(Figure 4.11).
On the other hand, the interviewees explained the strategies that could spearhead
policymakers’ engagement in strengthening MFF policies, including visualizing political rewards
associated with legislating for the greater good, managing objections effectively and anticipating
solutions to potential problems elicited by policymakers, promoting persuasive encounters
instead of intending to impose change (Figure 4.12), generating public awareness and support,
maintaining a flexible mindset to adapt to local contexts and changing situations, understanding
the decision-makers agenda, and explaining the positive cost/benefit balance of MFF policies
(Figure 4.13).
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Figure 4. 9 Theme 3: Bringing policymakers on board. Subtheme 8: Challenges part I

89

Figure 4. 10 Theme 3: Bringing policymakers on board. Subtheme 8: Challenges part II
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Figure 4. 11 Theme 3: Bringing policymakers on board. Subtheme 8: Challenges part III
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Figure 4. 12 Theme 3: Bringing policymakers on board. Subtheme 9: Strategies, part I
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Figure 4. 13 Theme 3: Bringing policymakers on board. Subtheme 9: Strategies, part II
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Integration of Quantitative and Qualitative Data
A joint display table was developed to illustrate how the qualitative results (expressed in
themes and direct quotes) enhance the quantitative results in terms of the most relevant determinant
factors grouped in the four MIDI categories (Table 4.8). The value added by the qualitative
explanations was interpreted to provide a deeper understanding of the MIDI questionnaire findings
and additional insights and nuances.

Table 4. 9 Joint display of quantitative (MIDI questionnaire) and qualitative (interviews) results
for the sequential explanatory integration of data on overcoming barriers and leveraging
facilitators to implement and disseminate the NeuroAdvocacy Toolkit

MIDI CATEGORY

OVERCOMING
BARRIERS AND
STRATEGICALLY
LEVERAGING OF
FACILITATORS

ILLUSTRATIVE QUOTES

Seizing the toolkit
attributes

GZ16: "As a strategy, it seems excellent
to me, it is very clear, very didactic, and
very easy to understand, obviously for
professionals who work on this, but I am
sure that it is so well laid out, so friendly
that a legislator or even a school teacher
can understand it perfectly."

Expansion of the
toolkit utilization to
other stakeholders

CD05: "It seems to me that it is a job
very well done, well planned, and above
all, empathic...it is not boring; it is
dynamic, helps to understand, it is
written and done with words and
phrases that are easy to understand, not
only for one as a surgeon, but for the
people, for the citizen, so I think the
language is very clear, precise, I think
everybody will understand it."

DETERMINANTS
ASSOCIATED WITH THE
TOOLKIT
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Training in toolkit use /
Preparedness to
manage objections

JJ10: “Learning to address the possible
objections they may raise in that first
discussion, try to solve those that the
legislators have placed there so that they
spend a very short period and move on
to the next step of the process.”

Subjective norm

JB20: "It seems to me that pediatric
neurosurgeons should support strategies
aimed at prevention and public health
because they do play a role in
transferring knowledge to the
population beyond the surgical work we
do."

Social norm

JJ10: “There would be no problem
because, within the statutes of the
pediatric chapter of our Neurosurgical
Association, one of the missions is to
support this type of initiative.”

Perceived roles

CC05: “We play a fundamental role in
society; we can change lives, and we
only have to want to do it and wish for it.
It is hard work. I’m not going to deny it.
It demands a lot of time and sacrifice,
not only physically because our surgeries
are very complex, but also time, family,
and resources because sometimes one
has to take part not only in clinical
practice and healthcare but also
dedicate time in contributing to society.”

Boosting effective
advocacy role

GP06: "Our role is crucial; since we are
pediatric neurosurgeons, we can
influence society not only from a clinical
or academic standpoint but also from an
administrative point of view and from
influencing public policies, although
there are few cases focused on this
point."

Alliances with
academic
institutions/other
societies

NZ08: “We need to work in collaboration
with societies, not only neurosurgery but
also gynecology and obstetrics, and
pediatrics because they also see the
complications of neural tube defects.
The more allies we get, the better. Also
consider urology, orthopedics, and the
Medical Women’s Association.”

DETERMINANTS
ASSOCIATED WITH THE
USERS

DETERMINANTS
ASSOCIATED WITH THE
ORGANIZATION
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DETERMINANT
ASSOCIATED WITH THE
SOCIOPOLITICAL CONTEXT

Support from
professional societies

JJ10: “The person going to do this must
receive significant backing and
support...they must have support at the
national level but also from ASOLANPED
at the Latin American level. Don’t let
them fight this fight alone.”

Support by nongovernmental
organizations (NGOs)

GC23: "Through a foundation, there are
foundations here that are highly
respected for their prestige, for their
help in every way to the most vulnerable
people, the poorest people, and these
foundations have much prestige and are
highly accepted by the political class and
by people in general."

Guild unity

CC05: “Not that I say one thing and
another person says, but I can do it this
other way; it would generate
disunity...Authority and information are
diluted, and policymakers, well, you see,
won’t give it importance...If we all work
together, and everyone moves in the
same direction, pulling the same boat, I
think that we can work wonders.”

Support by
supranational
organizations

RB14: “It is ideal to have the support of
organizations of the stature of the WHO
and PAHO. If we have an agreement or a
resolution from PAHO/WHO, it is a little
easier to go directly to the Ministry of
Health and gain their attention.”
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Chapter 5: Interpretations, Conclusions, and Recommendations
To date, this is the first study using a mixed-methods design to describe the determinant
factors for developing, implementing, and disseminating a knowledge translation strategy to
influence Latin American policymakers to strengthen MFF policies including folic acid to prevent
NTDs.
A mixed-methods design facilitates greater depth and stakeholder inclusion in several ways
described, in terms of this study, for the specific approach of policy implementation and
dissemination research (Brownson et al., 2018; Creswell & Plano Clark, 2017). First, mixedmethods designs are more suitable to involve participants in the study as relevant stakeholders to
understand the detailed nuances of promoting policy change and empowering and engaging them
in implementing the research findings that might impact their communities (Milat et al., 2014).
Second, strategies devised to translate knowledge aiming to influence policymakers’ decisions
benefit from a mixed-methods evaluation design to gather quantitative and qualitative data to
explore the involvement of individuals in the components of the intervention but also the
generation of change (Palinkas & Cooper, 2018). Third, bridging a knowledge gap in the
translational continuum requires broadening the approaches and leveraging opportunities for
collaboration; these conditions are possible with a mixed-methods approach and are more
complicated when conducting intradisciplinary quantitative or qualitative research independently
(Repko & Szostak, 2020). Fourth, a mixed-methods approach fosters the application of different
ontologies, epistemologies, and methodologies in one study, combined in a pragmatic worldview
or flowing in a dialectic stance (Creswell & Plano Clark, 2017); this feature stimulates dialogue
among investigators of different fields to create common ground on how to approach policy
change. Finally, mixed-methods approaches in translational research not only ensure greater cross-
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disciplinary inclusion but are also inclusive in the sense that non-academic participants can be an
active part of the generation, exchange, transfer, translation, utilization, and integration of
knowledge.
This study also represents the first formal validation of the MIDI questionnaire in Spanish
and the first time the instrument is applied to measure determinant factors of an innovation
targeting public policies to bridge the gap between the T3 and T4 moments of the translational
continuum. The instrument has proven helpful in the healthcare, welfare, informatics, and
education sectors; however, its generalizability to other settings had not been tested before this
study (Dugstad et al., 2019; Fleuren et al., 2014). Therefore, the authors of the MIDI invited
implementation researchers to use and explore the instrument in other settings where similar
processes may occur when implementing an innovation (Fleuren et al., 2014). For this study, the
MIDI offered an objective view of the determinants affecting the implementation of the
NeuroAdvocacy Toolkit as an innovation aiming to influence policymakers’ decisions regarding
fortification policies.
Using a knowledge transfer toolkit serves as a powerful aid in promoting policy change
(Barac et al., 2014). Although international neurosurgical organizations such as ASOLANPED
and the ISPN have issued a call to action and prompted member neurosurgeons to advocate for
MFF policies to prevent NTDs (Caceres et al., 2021; Dabdoub et al., 2014), their directives lacked
detailed guidelines on how to translate the evidence to influence government agents’ support of
the policy. The NeuroAdvocacy Toolkit represents a vehicle to channel efforts from the
neurosurgical community and convey strong messages to crucial decision-makers when
advocating for MFF policies to prevent NTDs. It could also serve as a model to facilitate advocacy
for other causes, such as primary prevention of traumatic brain and spine injury and prevention
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and early detection of central nervous system tumors in the pediatric population.
The scientific literature provides examples of using knowledge transfer toolkits in other
health settings, such as healthcare education and implementation of clinical practice guidelines
and health programs (Barac et al., 2014; Straus et al., 2013), as well as entirely different settings
to promote knowledge translation in areas such as finances (Carrillo et al., 2006), geospatial
science (Sajeva et al., 2020), foreign affairs (Napier, 2005), and science integration for secondary
schools (Guasch et al., 2020). This study is the first reported experience involving developing and
implementing a KT toolkit in the global neurosurgery field, which had great acceptance among the
neurosurgical community and almost unrestricted self-reported support, a crucial element when
implementing and disseminating an innovation (Brownson et al., 2018).
The NeuroAdvocacy Toolkit is a conduit for behavior change in KOL and policymakers.
It could even permeate other sectors and stakeholders. The main barriers to change within the
system related to evidence-informed policies imply ontological, methodological, and
epistemological challenges than can permeate intellectual, relational, and institutional levels
(Stevenson et al., 2012) but also real-world problems such as policymakers’ agenda and priorities.
On the other hand, potential facilitators to change include broadening the phenomenon to focus on
large-scale interventions, the use of more expansive methods that integrate different disciplines
and relevant stakeholders, public-private partnerships, network bridging, and institutional
alignment (Stevenson et al., 2012). Those barriers may be overcome, and the facilitators can and
should be leveraged by integrating a transdisciplinary generation of knowledge, translational
science, and a systems-thinking approach.
From a researcher and advocate’s experience, while conducting the study, the conceptual
framework specifically designed for this study (combining Kingdon’s multiple streams model
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(Kingdon, 2003, 2014) and Aarons’ model for assessing the determinant factors for the uptake of
evidence-based policies (Aarons et al., 2011)) was materialized through the actual implementation
of the NeuroAdvocacy Toolkit to approach and exchange knowledge with official agents at the
Colombian Ministry of Health. While governmental agendas are set in the problems or political
streams, solutions are usually generated in the policy stream. However, the possibility of items
rising on a decision agenda is enhanced if all three streams converge (Kingdon, 2014). Integrating
knowledge of the critical factors for policy implementation and seizing the window of opportunity
for brokering knowledge led to consolidating a formal process for a new resolution draft scaling
up the micronutrient fortification policy to include maize flour and rice in the Colombian
regulation. This new resolution is in progress for official governmental approval.
Moreover, the Colombian government sponsored an initiative to promote a WHO
resolution prompting the implementation of MFF policies worldwide, which is now on the agenda
for the next WHO Executive Board to be voted in the forthcoming World Health Assembly in May
2023. See in Appendix D the diplomatic concept note issued by Colombia as a member state of
the WHO Executive Board. The document was informed by drawing elements from the
NeuroAdvocacy Toolkit resulting from iterative processes and knowledge exchange interactions.
It is presented in this dissertation with permission from the Colombian authorities.
Interpretation of Specific Findings in the Study Phases
Needs assessment

Ninety percent of Latin American countries have a compelling necessity for regulatory
change regarding MFF policies. Generating change requires multiple stakeholders' involvement
and knowledge translation strategies to impulse actions by regional policymakers. This study
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confirms the NeuroAdvocacy Toolkit’s utility to serve in this capacity and presents an objective
way to determine priority elements according to the specific context of each country. Through a
customizable scale that allows the granular analysis of regulatory aspects and epidemiological
data, KOL and interdisciplinary teams can tailor advocacy activities to specific domains of MFF,
such as implementing the policy, improving enactment by the food industry, and optimizing the
policy surveillance or making national registries more robust.
Implementing and disseminating the NeuroAdvocacy Toolkit can convey a sense of
urgency at the decision-makers level by understanding the critical determinant factors and the
strategies explained in the following subsections.

Quantitative strand

Quantitative data obtained through the MIDI questionnaire were instrumental in
answering the research question: what are the determinant factors influencing the use of the
NeuroAdvocacy Toolkit as an innovation to promote robust MFF policies in Latin America? Key
opinion leaders in pediatric neurosurgery from the twenty countries helped determine 20
facilitators, seven potential facilitators, and two barriers to implementing the Toolkit as a
knowledge translation strategy to policymakers in the region.
Factors associated with the innovation, the users, and the sociopolitical context constitute
facilitators in implementing and disseminating the Toolkit; similarly, most factors related to the
organization are facilitators or potential facilitators and can be leveraged to achieve the goals. On
the other hand, two barriers were associated with the organization (neurosurgical societies). This
phenomenon responds to the fact that 38% of the survey respondents reported an absence of a
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formal pediatric neurosurgery chapter or organized society in their countries. When present,
nearly half of the participants mentioned that this society, chapter, or association does not
include missional activities to advise, promote or influence public policies concerning children's
health. Specific actions are needed to adjust the implementation and dissemination strategies for
these two factors, including meetings between ASOLANPED leadership and local neurosurgical
associations to formally ratify the initiative and boost advocacy and lobbying competencies in
designated team members.
Analyzing the determinant factors according to the country categories allows the local
KOLs, the national neurosurgical associations, and ASOLANPED leadership to customize
specific actions to enhance the implementation and dissemination strategies for the
NeuroAdvocacy toolkit.

Qualitative strand

The detailed descriptions in the qualitative phase of the study enabled answering the
qualitative research questions: how do the KOL describe their engagement, motivation, and
intention to act in implementing and disseminating the NeuroAdvocacy Toolkit to translate
knowledge to policymakers in their countries? And what are the perceptions of KOL about
appropriate dissemination mechanisms of the NeuroAdvocacy Toolkit? The codified qualitative
data allowed identifying three themes related to the implementation expressed as 1) the attitudes
toward using the Toolkit, 2) the ideal delivery strategies to policymakers, and 3) how to face
potential challenges to bring policymakers on board effectively during the implementation and
dissemination process.
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Participants described motivation in terms of empathy toward their patients and
caregivers, awareness of the high burden people living with NTD and their families have to face
along the vital cycle, and inspiration for doing a greater good. They described engagement in
terms of confidence in using the toolkit to broker knowledge to policymakers, gratification for
opportunities to advocate for an impactful evidence-based policy, and commitment to the
initiative. Intention to act was prompted by emulation of efforts and readiness to start the process
of implementing and disseminating the innovation. A few KOL also described potential
drawbacks during the implementation and dissemination of the KT strategy, namely hesitation to
participate due to time constraints, the anticipation of apathy or inertia leading to maintaining the
status quo, or frustration by not observing policymakers' use of the knowledge transferred to
them.
Participants described the strategies to deliver the toolkit in terms of ideal channels to
approach policymakers, including initiatives from organized neurosurgery and interdisciplinary
teams instead of individual efforts, involving patients and families associations and contacting
gatekeepers to facilitate the process. For the initial approach, participants favored in-person
meetings, maintaining openness and availability to explain the toolkit material and spontaneous
questions in lay terms and wrapping up the encounter with a call to action to policymakers
highlighting the specific further steps. They also emphasized the need for ongoing follow-up
activities such as scheduling new virtual or in-person meetings, e-mails, and phone calls, as well
as devising practical mechanisms to assess policymakers’ knowledge use in a way that they do
not feel evaluated or overwhelmed.
When bringing policymakers on board, participants identify potential challenges,
including laborious bureaucratic processes, lack of knowledge by decision-makers, distrust
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among stakeholders, indolence, cynicism, and negativity. The interviewed KOL identified
science skepticism as an emergent threat that has also been described for other fields in public
health, such as contagious diseases, vaccination, or climate change, and is usually linked to
science literacy (Rutjens et al., 2021, 2022; Scheitle & Corcoran, 2021). In parallel, participants
recognize strategies to defeat the identified challenges, namely generating public awareness
regarding NTDs and preventative strategies, using persuasion and objection management
techniques, making the policy’s favorable cost/benefit balance and the possibility of political
rewards visible to policymakers, and finally, being prepared to adapt to changing decisionmakers agendas and priorities.

Quantitative and qualitative integration
Integrating the quantitative and qualitative data permitted a deeper understanding of how
to overcome potential barriers and devise strategic leveraging of facilitating factors when
disseminating the Toolkit to the target policymakers. Achieving this integration required the
mixing of quantitative and qualitative data, which also enabled answering the mixed-methods
research question: in what ways do the interview data reporting the views of KOL about their
motivation, engagement, and intention to act help to explain the quantitative results about the
determinant factors for implementing the NeuroAdvocacy Toolkit?
After merging quantitative and qualitative data, the iterative analytic process provided
essential information through emergent themes and additional insights and nuances when aiming
to influence policymakers regarding MFF policies in Latin America. Although the MIDI allowed
identifying the main barriers and facilitators for implementing the NeuroAdvocacy Toolkit, the
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subsequent interviews allowed visualizing alternatives for operationalizing the determinant
factors. First, combining survey and interview data made more evident the elements of the toolkit
that make it suitable for the knowledge translation process and how to take advantage of those
attributes to expand the innovation to involve other stakeholders as potential users beyond the
neurosurgical community. Second, KOL behaviors influenced by subjective norms, social norms,
and perceived roles can spearhead effective data-driven advocacy. Third, organizational support
can enhance the implementation and dissemination of the NeuroAdvocacy Toolkit by
consolidating neurosurgical guild unity and promoting alliances with universities, other
academic institutions, and other professional societies, including nutrition, pediatrics, urology,
orthopedics, rehabilitation disciplines; also, obtaining support from non-governmental
organizations and patients’ associations as critical stakeholders. Fourth, gaining support from
supranational organizations such as the WHO and PAHO, materialized through a statement or
resolution, can accelerate the dissemination process and promote the promulgation, enactment,
and enforcement of MFF policies in most of the countries represented in this study.

Reflections on the knowledge translation process
This study generated knowledge regarding effective KT strategies to include an evidencebased public health measure to prevent NTDs into Latin American policymakers' agenda. The gap
between robust scientific evidence and policy implementation, i.e., from knowledge to action, has
surpassed three decades. By seizing the window of opportunity for knowledge brokering described
by Kingdon’s multiple streams model, the implementation and dissemination of the
NeuroAdvocacy Toolkit can aid in bridging the chasm between the T3 and T4 moments of the
translational research continuum regarding primary prevention of neural tube defects.
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The NeuroAdvocacy Toolkit development and refinement benefitted from evidenceinformed data and the rich perspectives of selected Latin American KOL and policymakers. The
implementation and dissemination of the innovative strategy also require the involvement and
interaction of multiple stakeholders and approaches that reflect the diverse perspectives and
mechanisms for the primary prevention of NTDs.
Stakeholder engagement, in this case, the involvement of Latin American pediatric
neurosurgeons as KOLs, can increase the likelihood that policymakers use the scientific evidence
to enhance the reach, adoption, implementation, scale-up, and sustainability of MFF as a robust
evidence-based policy to prevent NTDs. During the study, the KOL were exposed to the KT
strategy, reflected on their societal role, and experienced a renovated impulse to advocate for health
causes. This study also exemplifies how knowledge translation constitutes a productive way to
materialize actions in global neurosurgery.
The exposition of KOL to the NeuroAdvocacy Toolkit ignited the transformation of Latin
American pediatric neurosurgeons from being passive stakeholders to active change agents in MFF
with micronutrients as robust evidence-based policies to prevent congenital malformations.

Conclusions
Most Latin American countries have a compelling need to update, scale up, implement,
optimize surveillance, and guarantee the sustainability of mandatory food fortification policies to
prevent neural tube defects. The NeuroAdvocacy Toolkit is an innovative knowledge translation
strategy enabling key opinion leaders in pediatric neurosurgery to influence policymakers'
decisions toward strengthening fortification policies. Although the NeuroAdvocacy Toolkit was
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originally designed to be used by pediatric neurosurgeons, and this study tested its
implementation by users from that particular group, the toolkit attributes make it suitable to be
used by different actors willing to implement and disseminate it, with minimum training or
alteration of the core components.
Critical determinant factors can act as barriers or facilitators to implementing and
disseminating the Toolkit. Recognizing them is essential to tailor strategies to approach and call
policymakers to action, with the ultimate goal of saving thousands of children in Latin America
from being born with a devastating but preventable condition and promoting a healthy and
fulfilling start to their lives.
The role of pediatric neurosurgeons in caring for children with congenital malformations
extends beyond surgical care and includes advocacy initiatives to promote context-specific,
science-driven policies for preventing NTDs. Championing, advocating, and lobbying for MFF
policies exemplifies the Latin American pediatric neurosurgeons’ potential to impact the
population's health positively.
Recommendations
Although sociocultural and political differences among Latin American countries exist,
the following recommendations apply to the Latin American region at large, based on the
consistency and homogeneity of findings in this study regarding the determinant factors for
implementing the NeuroAdvocacy Toolkit as a KT strategy.

•

The implementation and dissemination process of the NeuroAdvocacy Toolkit
should consider specific contextual aspects and needs of each Latin American
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country.
•

The Toolkit contents should be translated into Portuguese for implementation and
dissemination in Brazil. In the case of Haiti, the contents should be translated into
French and Haitian Creole. In both cases, the idea is to bring on board multiple
stakeholders in those countries to support the initiative.

•

For some countries, greater consolidation of organized neurosurgery is ideal for
taking the initiative forward. ASOLANPED and large national societies can support
and advise small associations or groups of pediatric neurosurgeons, as well as
individual champions leading the process in countries without an evident
neurosurgical organization.

•

ASOLANPED can lead the formal ratification of the initiative and the
implementation and dissemination process by national societies of pediatric
neurosurgery in Latin America.

•

More junior neurosurgeons, residents, and fellows can benefit from training in
communication, persuasion, advocacy, and lobbying techniques to enhance their
abilities as key opinion leaders.

•

Senior pediatric neurosurgeons can reorient efforts at this stage of their careers to
take advantage of their experience and wisdom to lead the way and guide younger
colleagues in advocacy and lobbying activities.

•

Gatekeepers can facilitate initial contact with policymakers and pave the way to
more productive interactions.

•

In-person meetings are ideal for the first approach to policymakers, followed by
diverse and creative ways to follow up and measure knowledge utilization.
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•

A resolution by a supranational organization such as the WHO encouraging
member states to adopt or strengthen existing MFF policies will serve as a catalyst
to accelerate the process and dilute potential resistance from particular
stakeholders.

•

Advocating for primary prevention of NTDs by no means implies impairing
continuous efforts to provide quality, humane and person-centered care to
individuals living with neural tube defects. Quite the opposite, those individuals
generate a source of inspiration to expand the horizons for innovative ways of
incorporating meaning in a pediatric neurosurgery career.

Implications for Future Research
When MFF are effectively implemented, enacted, and enforced, they bring about consistent
health outcomes in the population by reducing the prevalence of NTDs by approximately 50%
after three to five years of implementation. For Latin America, new inquiries elicited from the
findings presented here but beyond the scope of this study include the following research
questions:
•

What is the degree of fidelity in delivering the KT intervention?

•

What elements of the dissemination strategy require flexibility to respond to
specific contextual factors?

•

How is the reception of evidence-based policy-related information by
policymakers?

•

How well does the intervention inform and motivate policymakers to address this
problem?
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•

How effective are the strategies for disseminating and translating knowledge in
generating uptake of the program?

•

How did the program permeate different levels or sectors related to the policy to
support its enactment and enforcement?

•

How do we ensure the sustainability of the KT strategy in promoting knowledge
use to achieve health outcomes?

Objective indicators in future research efforts should include implementation and
dissemination science outcomes such as self-reported support of the policies, self-reported
knowledge use, and observed knowledge use by policymakers (Brownson et al., 2018). Teachout
et al. described a framework for conducting implementation science research in large-scale food
fortification programs (Teachout et al., 2021) that can be helpful in future research initiatives
derived from the promulgation and enactment of MFF policies. Another objective indicator of the
impact of MFF policies is the periodical assessment of blood folate levels in women of
reproductive age as a monitoring and evaluation measure (Bailey & Hausman, 2018).
After proper translation and adaptation, the NeuroAdvocacy Toolkit has the potential to
serve as a KT strategy for other world regions, which will necessarily elicit new research questions
regarding the determinant factors for implementing and disseminating the innovative strategy
outside Latin American countries.
Like translational science, global neurosurgery is a young field of research. Both will
benefit from growing research ideas to address unmet needs from interdisciplinary and diverse
perspectives. Promulgation, enactment, and enforcement of MFF policies are the first steps of a
long process that requires using a lens that accounts for the complexity of the process and
stakeholder mapping and involvement to guarantee the sustainability of micronutrient fortification
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policies and the prevention of congenital disorders. In addition to policymakers, critical
stakeholders are the food industry, distributors (including importers and exporters), consumers,
clinicians of different fields, and patient associations. They can be natural allies in the quest to
prevent NTDs and other congenital malformations through MFF policies.
Other preventable causes of NTDs also require building a body of evidence to promote
further knowledge translation. Non-folate-sensitive NTDs constitute a large window of
opportunity to generate translational knowledge in different moments of the research spectrum.
Application to Other Settings
Although the findings of this study are generalizable to Latin American countries regarding
MFF policies, the procedures carried out in this research can inspire the conduction of similar
studies in other world regions and other fields of research in global neurosurgery. The scale to
assess the needs for regulatory change presented in this dissertation applies to different continents
and other situations of interest in preventing neurosurgical conditions.
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APPENDIX A: Phase 1. Interview protocol to policymakers

Thank you for agreeing to participate in this study. This interview will be recorded, and only the
audio component of the recording will be transcribed. All the materials will be destroyed after the
completion of the study. All the answers will be confidential, and you are encouraged not to use
specific names. Please, feel free to answer all questions or pass on any questions that might make
you uncomfortable or do not want to answer.
If that is OK with you, I will start the recording now.
1. Exploratory question: Please, state your name and current position in (state agency or
legislative body). For how long have you been appointed to this position? What are the roles
of your team members?
2. Leading question: When you or your team need scientific information to guide your decisions,
what mechanisms do you usually employ to obtain that information?
a. Follow-up question: How are those mechanisms working for you?
b. Follow-up question: What are the main challenges when gathering scientific
information?
c. Follow-up question: What strategies do you use to overcome those challenges?
3. Leading question: Tell me about your experience in applying and monitoring current
legislation on mandatory food fortification
a. Follow-up question: In your opinion, what are the main obstacles to implementing food
fortification programs
b. Follow-up question: What factors make it easier to implement such programs?
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c. Follow-up questions: What would you consider crucial aspects in monitoring the
application of current policies?
4. Leading question: Are there any plans for other food fortification policies to improve human
health conducted by the (state agency or legislative body)?
a. Follow-up question: What kind of evidence do you or your team usually seek when
designing a policy for mandatory food fortification?
b. Follow-up question: What would be your preferred mechanisms and formats to receive
and use evidence-based knowledge?
5. Leading question: What would be the role of an expert in the field when exchanging knowledge
to inform your decisions?
a. Follow-up question: What would be the ideal ways for that expert to convey the
knowledge so you and your team can readily use it to inform your decisions?
b. Follow-up question: How can a toolkit containing slides, infographics, evidence briefs,
and executive summaries of successful legislation serve the purposes of obtaining and
using evidence-based knowledge?
c. Follow-up question: What other elements would you add to such a toolkit?
6. Is there any comment you would like to add to what you have shared in this interview?
Thank you very much for participating in this interview. If necessary, would it be OK to
contact you for further follow-up questions about this interview?
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APPENDIX B: Phase 2. Adaptation and operationalization of the MIDI questionnaire

THE NEUROADVOCACY TOOLKIT:
DESCRIPTION AND OPERATIONALIZATION OF THE DETERMINANTS OF INNOVATION
MEASUREMENT INSTRUMENT (MIDI)
Determinants associated with the innovation
Determinant

Name

Description

Operationalization

1

Procedural clarity

The extent to which the
innovation is described in
clear steps/procedures.

The NeuroAdvocacy Toolkit clearly
describes the activities I should
perform and in which order.

Correctness

The degree to which the
innovation is based on
factually correct
knowledge

The NeuroAdvocacy Toolkit is
based on factually correct
knowledge

3

Completeness

The degree to which the
activities described in the
innovation are complete

The NeuroAdvocacy Toolkit
provides all the information and
materials needed to work with it
properly

4

Complexity

The degree to which the
implementation of the
innovation is complex

The NeuroAdvocacy Toolkit is too
complex for me to use

2

5

6

Compatibility

Observability

The degree to which the
innovation is compatible
with the values and
working method in place
Visibility of the
outcomes for the user, for
example, whether the
outcomes of a particular
treatment are clear to the
user

The NeuroAdvocacy Toolkit is a
good match for how I am used to
working

The outcomes of using the
NeuroAdvocacy Toolkit are clearly
observable

Response scale
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
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7

Relevance for the
target audience

The degree to which the
user believes the
innovation is relevant to
the target audience

I think the NeuroAdvocacy Toolkit
is relevant for the policymakers in
my country
I think the intended effects of the
NeuroAdvocacy Toolkit are relevant
to the population of my country

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree

Determinants associated with the user
Determinant

Name

Description

Operationalization

Response scale

Using the NeuroAdvocacy Toolkit
means I can contribute significantly
to my neurosurgical society and, in
general, to children in my country.

8

Personal
benefits/drawbacks

The degree to which
using the innovation has
advantages or
disadvantages for the
users themselves

Using the NeuroAdvocacy Toolkit
can be time-consuming and add
extra workload to my regular
activities

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree

Will using the NeuroAdvocacy
Toolkit make my work as a pediatric
neurosurgeon more valuable since I
will see fewer children with
devastating neural tube defects

9

Outcome
expectations

Importance: Policymakers should be
more aware of the impact of neural
tube defects on the individual,
Perceived probability and
family, society, and public health
importance of achieving
levels
the client objectives as
intended by the
Probability:
innovation
I expect that using the
NeuroAdvocacy Toolkit will
achieve that policymakers will take

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) most definitely not, (2)
definitely not, (3) perhaps
not, perhaps (4) definitely,
(5) most definitely
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action to improve fortification
policies.

10

Professional
obligation

11

Client satisfaction

12

Client cooperation

13

Social support

I feel it is my responsibility as a
The degree to which the
professional and member of my
innovation fits in with the
national neurosurgical society to use
tasks for which the user
the NeuroAdvocacy Toolkit to
feels responsible when
encourage policymakers to improve
doing their work
fortification policies
The degree to which the
user expects the target
audience to be satisfied
with the innovation
The degree to which the
user expects the target
audience to cooperate
with the innovation
Support experienced or
expected by the user
from important social
referents relating to the
use of the innovation (for
example, from
colleagues, other
professionals they work
with, heads of

Policymakers will generally find it
useful if I deliver the
NeuroAdvocacy Toolkit to them
Policymakers will generally
cooperate if I use the
NeuroAdvocacy Toolkit

I can count on adequate assistance
from my national neurosurgical
society if I need it to use the
NeuroAdvocacy Toolkit

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
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department, or
management)
I can count on adequate assistance
from the Latin American
Association of Pediatric
Neurosurgery (ASOLANPED) if I
need to use the NeuroAdvocacy
Toolkit

14

15

16

17

Descriptive norm

Subjective norm

Self-efficacy

Knowledge

Colleagues' observed
behavior: the degree to
which colleagues use the
innovation

The influence of
important others on the
use of the innovation

The degree to which the
user believes they can
implement the activities
involved in the
innovation
The degree to which the
user has the knowledge
needed to use the
innovation

In your opinion, what proportion of
the colleagues in your national
neurosurgical society will use the
NeuroAdvocacy Toolkit?
Normative beliefs: To what extent
do the members of your
neurosurgical society expect you to
use the NeuroAdvocacy Toolkit?

(1) not a single colleague (2)
almost no colleagues (3) a
minority (4) half (5) a
majority (6) almost all
colleagues (7) all colleagues
(1) most definitely not, (2)
definitely not, (3) perhaps
not, perhaps (4) definitely,
(5) most definitely

Motivation to comply: When it
comes to working in accordance
with the NeuroAdvocacy Toolkit, to
what extent do you comply with the
opinions of the ASOLANPED?

(1) very little (2) little (3) not
a little, not a lot (4) a lot (5)
a great deal

Do you think you can put the
NeuroAdvocacy Toolkit into
practice?

(1) most definitely not, (2)
definitely not, (3) perhaps
not, perhaps (4) definitely,
(5) most definitely

I know enough to use the
NeuroAdvocacy Toolkit.

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
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18

Awareness of
content of
innovation

The degree to which the
user has learned about
the content of the
innovation

To what extent are you informed
about the content of the
NeuroAdvocacy Toolkit?

(1) I'm not familiar with the
innovation (2) I'm familiar
with the innovation, but I
haven't read it through (yet)
(3) I'm familiar with the
innovation, and I have
glanced through it (4) I'm
familiar with the innovation,
and I have read through it
thoroughly

Determinants associated with the organization
Determinant

19

Name

Formal ratification
by management

Description
Formal ratification of the
innovation by
management, for
example, by including
using the innovation in
policy documents.

Operationalization

Response scale

Has your national neurosurgical
society set up formal arrangements
relating to the use of the
NeuroAdvocacy Toolkit (in policy
plans, work plans, and others)

(1) no (2) yes

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree

Replacement when
staff leave

Replacement of staff
leaving the organization

In my national neurosurgical
society, there are arrangements in
place so that staff who use the
NeuroAdvocacy Toolkit and leave
the organization are replaced in
good time by staff who are/will be
adequately prepared to take over

21

Staff capacity

Adequate staffing in the
department or in the
organization where the
innovation is being used

There are enough people in our
national neurosurgical society to use
the NeuroAdvocacy Toolkit as
intended

22

Financial
resources

Availability of financial
resources needed to use
the innovation

There are enough financial
resources available to use the
NeuroAdvocacy Toolkit as intended

20

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
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Time available

Amount of time available
to use the innovation

Our national neurosurgical society
provides me with enough time to
include the NeuroAdvocacy Toolkit
as intended in my yearly activities

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree

Material resources
and facilities

Presence of materials and
other resources or
facilities necessary for
the use of the innovation
as intended (such as
equipment, materials, or
space)

Our organization provides me with
enough materials and other
resources or facilities necessary for
the use of the NeuroAdvocacy
Toolkit as intended

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree

Coordinator

The presence of one or
more persons responsible
for coordinating the
implementation of the
innovation in the
organization

In my organization, one or more
people have been designated to
coordinate the process of
implementing the delivery of the
NeuroAdvocacy Toolkit

(1) no (2) yes

26

Unsettled
organization

The degree to which
there are other changes in
progress (organizational
In addition to implementing the
or otherwise) that
NeuroAdvocacy Toolkit, are there
represent obstacles to the
any other organizational changes
process of implementing
affecting the implementation of the
the innovation, such as
innovation now or in the foreseeable
re-organizations,
future (reorganization, merger, cuts,
mergers, cuts, staffing
staffing changes, other
changes, or the
innovations)?
simultaneous
implementation of
different innovations

27

Information
accessible about
the use of
innovation

23

24

25

Accessibility of
information about the use
of the innovation

It is easy for me to find information
in my organization about using the
NeuroAdvocacy Toolkit as intended

(1) no (2) yes

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
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28

Feedback to the user
about progress with the
innovation process

Performance
feedback

In my neurosurgical association,
feedback is regularly provided about
progress with the use of the
NeuroAdvocacy Toolkit

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree

Determinants associated with the socio-political context
Determinant

Name

29

Legislation and
regulations

Description
The degree to which the
innovation fits in with
existing legislation and
regulations established
by the competent
authorities

Operationalization

Response scale

The activities listed in the
innovation fit in well with existing
legislation and regulations

(1) totally disagree, (2)
disagree, (3) neither agree
nor disagree, (4) agree, (5)
totally agree
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APPENDIX C: Phase 3. Interview protocol to key opinion leaders

Thank you for agreeing to participate in this study. This interview will be recorded, and only the
audio component of the recording will be transcribed. All the materials will be destroyed after the
completion of the study. All the answers will be confidential, and you are encouraged not to use
specific names. Please, feel free to answer all questions or pass on any questions that might make
you uncomfortable or do not want to answer.
If that is OK with you, I will start the recording now.
1. Exploratory question: Please, state your name and current position in your national society
for pediatric neurosurgery. For how long have you been appointed to this position? What
are your roles in the organization?
2. Leading question: Tell me about your opinion on the role of pediatric neurosurgeons as
health advocates.
a. Follow-up question: Walk me through your experiences in advocating for health
initiatives.
b. Follow-up question: How does it make you feel when participating in such
initiatives?
c. Follow-up question: What benefits does participation in these activities bring for a
medical specialist like you?
3. Leading question: What are the main challenges when advocating for a health cause?
a. Follow-up question: What strategies do you use to overcome those challenges?
b. Follow-up question: Are there any potential drawbacks when participating in such
causes?
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4. Leading question: To your knowledge, are there any plans for further food fortification
policies to improve human health in your country?
a. Follow-up question: What kind of evidence do you think policymakers usually seek
when designing a policy for mandatory food fortification?
b. Follow-up question: What would be the preferred mechanisms and formats to
receive and use evidence-based knowledge in your country?
5. Leading question: After being introduced to the NeuroAdvocacy Toolkit, tell me about
your general opinion on the toolkit as a strategy to translate knowledge to policymakers
a. Follow-up question: In your opinion, what elements of the toolkit make it suitable
for knowledge transfer to policymakers?
b. Follow-up question: What element, if any, would you change to enhance the
likelihood that the toolkit meets its purpose?
6. Leading question: How motivated do you feel, like an expert in the field, to use the
NeuroAdvocacy Toolkit to inform policymakers’ decisions?
a. Follow-up question: What would be the ideal ways to approach those
policymakers?
b. Follow-up question: What mechanisms do you think will be more effective when
trying to deliver the NeuroAdvocacy Toolkit to the policymakers?
c. Follow-up question: What obstacles, if any, do you anticipate when approaching
policymakers and delivering the toolkit?
d. Follow-up question: What circumstances would make it easier to deliver the toolkit
to policymakers?
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7. Leading question: After delivering the NeuroAdvocacy Toolkit, what would be a good way
to follow up on the knowledge utilization by the policymakers?
a. Follow-up question: To what extent would you be willing to be contacted again by
the policymakers for follow-up questions?
b. Follow-up question: To what extent would you like to contact policymakers for
further verification of knowledge use?
8. Is there any comment you would like to add to what you have shared in this interview?
Thank you very much for participating in this interview. If necessary, would it be OK to
contact you for further follow-up questions about this interview?
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APPENDIX D. Diplomatic Concept Note from the Colombian Government to the World
Health Organization Secretariat

Government of Colombia
Ministry of Health and Ministry of Foreign Affairs
Concept Note
Proposed agenda item - Prevention of congenital malformations through food fortification
with micronutrients and draft resolution
Context
The 63rd World Health Assembly, held in 2010, reviewed the report on congenital malformations
prepared by the WHO Secretariat and its importance as a cause of prenatal and neonatal
mortality, as well as mortality in children under five years of age. As a result, the WHA adopted
resolution WHA63.17, recognizing that congenital disorders are due to various causes and
determinants, including preventable factors such as infectious or nutritional factors. The text also
promoted primary prevention and improvement of the health of children with congenital
disorders and requested the Member states to:
•
•
•

•
•
•

Develop and strengthen registration and surveillance systems as recommended by WHONutrition in collaboration with other departments and the USCDC.
Develop expertise and build capacity for the prevention of congenital disorders and care of
affected children;
Increase coverage, allocate resources, and formulate plans for effective prevention
measures, including vaccination against rubella, folic acid supplementation, and programs
addressing tobacco and alcohol use among pregnant women and women who are trying to
conceive;
Raise awareness of the importance of newborn screening programs and their role in
identifying infants born with congenital malformations;
Support families who have children with congenital malformations and associated
disabilities;
Strengthen research on major congenital disorders and promote international cooperation
to prevent them.

Additionally, the resolution requested the Director General to support the Member States in
developing national plans for implementation of effective interventions to prevent and manage
congenital malformations within their national maternal, newborn, and child health plan,
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strengthening health systems and primary care, including improved coverage of vaccination
against diseases such as measles and rubella, of addressing tobacco and alcohol use among
pregnant women and women trying to conceive, along with food fortification strategies, for the
prevention of congenital malformations, and promoting equitable access to such services.
However, this resolution, adopted more than ten years ago, was the latest mandate from the
World Health Assembly to the Member States and the WHO Secretariat on these causes of
prenatal and neonatal mortality, which continue to be of significant impact and importance.
According to the World Health Organization (WHO), 303,000 newborns die yearly in the first
four weeks of life due to congenital anomalies. The most common and severe congenital
disorders are neural tube defects, including spina bifida, encephalocele, anencephaly, cardiac
malformations, and Down syndrome. Although it is not possible to assign a specific cause to
about 50% of congenital anomalies, some causes and risk factors have been identified, such as
socioeconomic and demographic factors, genetic factors, infections, maternal nutritional status,
and environmental factors.
In this sense, the WHO has stated that it is possible to prevent some congenital anomalies, for
example, with fundamental preventive measures such as vaccination, sufficient intake of folic
acid and iodine by women of reproductive age, ensuring an adequate supply of vitamins and
minerals in the diet (through the fortification of staple foods or the provision of supplements), as
well as appropriate prenatal care.
Colombia recognizes neural tube defects, such as anencephaly, encephalocele, and spina bifida,
as among the most severe congenital disorders. Worldwide, 300,000 children are born with this
condition, and 100,000 will die unnecessarily each year. Regarding the morbidity of these
diseases, children who survive these congenital anomalies have a lifelong neurological
impairment and require multiple surgeries, a significant need for complex care that,
unfortunately, is never curative.
Although most neural tube defects are multifactorial in origin, folic acid deficiency or insufficiency
during the periconceptional stage directly correlates with the prevalence of these defects. The
scientific evidence has shown that most neural tube defects are sensitive to maternal folic acid
levels and can be prevented by mandatory fortifying foods such as wheat, corn, rice, or other
staple foods with folic acid. However, only 23% of these congenital disorders are currently being
prevented worldwide.
A recent call to action from the scientific community, published in The Lancet Global Health, urges
the World Health Assembly to pass a resolution for universal mandatory folic acid fortification.
Such a resolution could accelerate the slow pace of spina bifida and anencephaly prevention
globally and assist countries in reaching their 2030 Sustainable Development Goals on child
mortality and health equity. The cost of inaction is profound and disproportionately impacts
susceptible populations in low-income and middle-income countries.
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Benefits of fortifying staple foods with micronutrients
Food fortification was discussed at the United Nations Food Systems Summit 2021 and Nutrition
for Growth 2021, where investment and government commitments took place. Some particular
benefits of fortifying foods with micronutrients are described below:
1. Food fortification ensures adequate levels of maternal micronutrients like folic acid
before conception. Most congenital malformations and disorders, such as spina bifida and
other neural tube defects, uniformly occur before pregnancy is known, making vitamin
supplements taken during pregnancy ineffective.
2. Although folic acid supplementation is effective when started at least three months
preconceptionally, this measure has limited coverage since less than half of pregnancies
are planned, and only 4% of women of reproductive age take oral supplements.
Moreover, adolescents and vulnerable populations that cannot access health services are
left unprotected.
3. Only mandatory fortification of staple foods results in widespread maternal micronutrient
levels sufficient to prevent spina bifida and other congenital malformations.
4. At the recommended levels, large-scale fortification with micronutrients, including folic
acid (vitamin B9), iron, vitamin A, iodine, and zinc, is very safe, effective, and costbeneficial. For example, incidence rates of spina bifida in countries with fortification are
consistently 8/10,000 live births. Rates without fortification are orders of magnitude
higher (50-120/10,000 with focal epidemics of >150/10,000).
5. In terms of the cost-effectiveness of this prevention measure, every dollar invested in
fortification results in many thousands of dollars of savings in future health care costs. For
instance, the cost per death averted through mandatory folic acid fortification is
estimated to be U$957.
6. Iron, folic acid, zinc, vitamin A, and other B vitamins help prevent nutritional anemia,
which improves productivity, maternal health, and cognitive development.
7. Fortifying with folic acid may also have a role in the child's mental health.
8. Zinc helps children develop, strengthens immune systems, and lessens complications
from diarrhea.
9. Vitamin A helps individuals fight infections and helps prevent childhood blindness.
Objectives of the inclusion of the prevention of congenital malformations as an agenda item of
the 76th WHA in 2023.
Given that congenital malformations are a public health problem, Colombia has considered it
essential to revitalize and promote within the WHO the agenda on the preventive approach to
congenital malformations. These disorders include spina bifida, anencephaly, other neural tube
defects, cardiovascular malformations, cleft lip and palate, and other congenital disorders.
Consequently, Colombia requests to incorporate this item in the 152nd Session of the WHO
Executive Board to be held in January 2023.
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The proposed novel resolution, to be discussed and agreed upon by the Member States, brings
together the synergies of food and health systems and seeks the following objectives:
•

•
•
•

•

•

Decrease inequities in the access to quality food and health interventions through social
protection measures for the population's most vulnerable and disadvantaged sectors by
articulating the synergies of the food and health systems.
Diminish the unnecessary and costly allocation of resources and efforts to treat conditions
that are by other means preventable
Mitigate the impact that preventable congenital malformations have on public health
systems, society, families, and individuals
Promote that WHO Member States strengthen their commitment to the prevention of
congenital malformations and other conditions as part of their regular health programs
and maternal and child health promotion through mandatory fortification of staple
foods with folic acid, iron, vitamin A, iodine, and zinc, according to each country's
context, needs, ethnicity, and cultural realities
Facilitate the promulgation, update, optimization, scaling up, implementation, and
surveillance of fortification policies with harmonized standards in line with WHO
recommendations to achieve a population impact.
Promote the integration of multiple stakeholders and sectors in articulating efforts to
implement sustainable large-scale fortification while supporting periodic monitoring and
surveillance of fortification status, fulfillment of harmonized standards, quality control of
enriched products, and micronutrient serum levels among women of reproductive age

Impact on Sustainable Development Goals (SDGs)
Food fortification with micronutrients such as folic acid, iron, vitamin A, iodine, and zinc has a
direct impact on at least three SDGs and three targets, as depicted in the following table:
SDG

DESCRIPTION TARGET

End hunger,
achieve food
security and
improved
nutrition,
and promote
sustainable
agriculture

2.2

TANGIBLE IMPACT OF
THE PROPOSED
RESOLUTION
By 2030, end all forms Different multinational
of malnutrition,
surveys demonstrate
including achieving, by that folate deficiency
2025, the
and insufficiency are
internationally agreed endemic worldwide
targets on stunting
among women of
and wasting in
reproductive age.
children under 5 years Population maternal
of age, and address
folate levels correlate
the nutritional needs
directly with the
DESCRIPTION
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of adolescent girls,
pregnant and lactating
women, and older
persons

3.2

Ensure
healthy lives
and promote
well-being
for all at all
ages

3.4

population incidence of
spina bifida,
anencephaly, other
neural tube defects,
major cardiovascular
malformations, cleft lip
and palate, and other
congenital conditions.
Large-scale food
fortification with
micronutrients is an
efficacious, costeffective, safe, and
feasible measure to
address the nutritional
needs of adolescent girls,
women of reproductive
age, and pregnant and
lactating women.
By 2030, end
Large-scale food
preventable deaths of fortification with
newborns and
micronutrients aids in
children under 5 years the reduction of anemia
of age, with all
by 50% and the
countries aiming to
reduction of low birth
reduce neonatal
weight. It also decreases
mortality to at least as iodine deficiency
low as 12 per 1,000
disorders such as brain
live births and under-5 damage to millions of
mortality to at least as children, goiter,
low as 25 per 1,000
cretinism, stillbirth,
live births
miscarriage, and physical
impairment. Class I
medical evidence for
By 2030, reduce by
over 30 years
one-third premature
demonstrates the
mortality from noneffectiveness of
communicable
mandatory folic acid
diseases through
fortification in reducing
prevention and
spina bifida,
treatment and
anencephaly, and other
promote mental
neural tube defects,
health and well-being
along with other
systemic congenital
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Reduce
inequality
within and
among
countries

10.3

Ensure equal
opportunity and
reduce inequalities of
outcome, including by
eliminating
discriminatory laws,
policies, and practices
and promoting
appropriate
legislation, policies,
and action in this
regard

malformations.
Additionally, this
evidence-based policy
prevents other
conditions like visual and
skin disorders related to
vitamin A deficiency,
gastrointestinal
disorders, and cognitive
impairment related to
zinc deficiencies, among
other diseases.
Being born with a
preventable disability is
a clear source of
inequality, particularly
affecting vulnerable
populations. Public
policies enforcing
mandatory fortification
of staple foods with
micronutrients will help
overcome inequities in
the access to quality
food and robust
evidence-based public
health interventions

Documents supporting the proposed resolution for food fortification with micronutrients to
prevent congenital malformations and other disorders:
•
•
•
•
•
•

https://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_10-sp.pdf
https://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R17-sp.pdf
WHO/CDC/ICBDSR. Birth defects surveillance: a manual for programme managers.
Geneva: World Health Organization; 2014.
WHO/CDC/ICBDSR. Birth defects surveillance: atlas of selected congenital anomalies.
Geneva: World Health Organization; 2014.
Birth defects surveillance: a manual for programme managers, second edition. Geneva:
World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO
Birth defects surveillance: quick reference handbook of selected congenital anomalies
and infections. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
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•
•

•
•
•

•
•

Birth defects fact sheet. Updated February 2022 https://www.who.int/news-room/factsheets/detail/birth-defects
Comprehensive implementation plan on maternal, infant, and young child nutrition.
http://apps.who.int/iris/bitstream/handle/10665/113048/WHO_NMH_NHD_14.1_eng.
pdf;jsessionid=0D5460B0638196F0A94C6E905FB4CA45?sequence=1
FAO Second International Conference of Nutrition - Framework for action.
Recommendation 42. https://www.fao.org/3/i4465e/i4465e.pdf
WHA58.24. https://apps.who.int/gb/ebwha/pdf_files/WHA58/WHA58_24-en.pdf
UN Food systems summit 2021: the coalition for healthy diets.
https://www.who.int/initiatives/food-systems-for-health/the-coalition-of-action-onhealthy-diets-from-sustainable-food-systems-for-children-and-all
Why fortify: Save Lives: https://www.ffinetwork.org/savelives
Preventing birth defects, saving lives, and promoting health equity: an urgent call to
action for universal mandatory food fortification with folic acid. The Lancet Global Health.
https://www.sciencedirect.com/science/article/pii/S2214109X22002133

***
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بسم هللا الرحمن الرحيم
In the name of Allah, the Merciful
En el nombre de Allah, el Misericordioso

